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ABSTRACT 
An initial assessment in stranded marine mammals, including evaluation of clinico-pathological 
variables, is a preliminary and critical step to define treatment and assessing the suitability of the 
animals for rehabilitation. Serum protein electrophoresis (SPE) is the most reliable method to 
determine the distribution of serum protein fractions and it is considered an essential step to 
evaluate the health status of animals, providing clinical useful information. The measurement of 
APPs in association to serum proteins’ fractions can supplement and extend the baseline 
information obtained from the complete blood cell count, fibrinogen, and standard serum chemistry 
panel.  
The thesis is divided in two main chapters, the first one focused on the serum protein 
electrophoresis (SPE) and the second one on the acute phase proteins evaluation 
In the first chapter, 38 under human care bottlenose dolphin serum samples were screened with 
agarose gel electrophoresis (AGE) to determine the reference intervals (RIs) of the serum proteins. 
Four main protein fractions were evident in all the animals tested: albumin, α-globulins, β-
globulins, and γ-globulins. The RIs for the serum protein fractions were: albumin 45.0 ± 4.0 g/L, α-
globulins 8.0 ± 1.0 g/L, β-globulins 5.0 ± 2.0 g/L, and γ-globulins 7.0 ± 2.0 g/L. Compared to 
previously published data in free ranging bottlenose dolphins, in our samples the concentration of 
total protein, α-globulins, and γ-globulins were slightly lower, while the concentration of albumin 
and the albumin/globulins ratio were slightly higher. The lower concentration of ‘’inflammatory’’ 
proteins associated to a higher concentration of albumin and the consequent higher 
albumin/globulins ratio reported in our study could reflect a lower antigenic stimuli in the animals 
housed in aquaria compared to the free-ranging populations. Moreover, in 8 electropherograms, we 
noticed that the base of the albumin peak was wider compared to the electropherograms of the other 
animals. For this reason, the same serum samples used for AGE were evaluated also with capillary 
zone electrophoresis (CZE), a more sensitive electrophoretic method. With CZE 9 out of 38 
samples showed a double albumin peak. However, all these samples except 2 had an albumin peak 
wider than that observed with AGE in dolphins classified as non bisalbuminemic by CZE; 
furthermore a wider albumin peak was also noted with AGE in one sample with normal CZE 
profile. We report for the first time the presence of hereditary bisalbuminemia in two groups of 
related bottlenose dolphins identified by means of CZE and we confirm that AGE could fail in the 
identification of this alteration. 
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To understand the genetic basis of bisalbuminemia, the albumin gene of 15 bottlenose dolphins 
belonging to two distinct families were reconstructed by direct comparison of its full length cDNAs 
with the provisional sequence of bottlenose dolphin albumin gene. Eighteen albumin gene 
variations were identified in the bottlenose dolphins studied (15 non-synonimous and 3 
synonymous). In order to identify the non-synonimous variations able to cause bisalbuminemia, the 
genotype-phenotype correlations within the two families were studied. Two heterozygous non-
synonymous variations that co-segregate with the ‘’bisalbuminemia’’ phenotype detected by SPE 
were identified: c.483C>G p.Phe146Leu in exon 4 and c.487T>C p.Tyr163His in exon 5. The 
genetic analysis of bottlenose dolphins’ albumin gene showed a significant polymorphism and two 
mutations associated with bisalbuminemia. Moreover, we were able to identify the autosomal 
codominant trait of this condition in dolphins, a similar pattern of inheritance to that in humans. The 
in silico analysis and the comparison between dolphin and human variations support the hypothesis 
that the variation p.Tyr163His could be more likely responsible for bisalbuminemia. 
In the second chapter double radial immunodiffusion (DRI), western blot (WB) analysis, and 
spectrophotometric measurement using immunologic or enzymatic assays were employed on serum 
samples of bottlenose dolphins and striped dolphins to validate, establish RIs, and evaluate the 
diagnostic accuracy of two positive acute phase proteins (C-reactive protein, CRP and serum 
amyloid-A, SAA) and one negative APP (serum paraoxonase-1, PON-1). With DRI none of the 
antibodies (Abs) against CRP and SAA cross-reacted with the serum samples of bottlenose dolphins 
and striped dolphins. Both the anti-SAA Abs tested were latex-conjugated, because produced for 
automatic immunoturbidimetric assays. The presence of latex associated to the Abs may have 
interfered to the migration of the Abs across the agarose gel. 
WB analysis for anti-CRP antibodies showed a weak positivity for striped dolphins and a pattern of 
positivity in the serum samples of bottlenose dolphins similar to those observed in dog, with 
multiple bands. However, we are not able to exclude the possibility that this pattern may represent 
an unspecific signal. The discouraging result obtained with the automated measurement of dolphins 
CRP (0.00 mg/L) seemed to confirm the hypothesis that the anti-human CRP Ab used does not 
recognize the cetaceans’ CRP, based also on the low homology of the amino acid sequence. On 
contrary, the SAA is highly conserved between different species. The automated measurement of 
SAA provided results with good precision; the SAA concentration in the whole set of bottlenose 
dolphins samples was 8.7 ± 11.8 mg/L. In addition, for the SAA concentration no differences were 
noted between different storage time, between the sex of the animals, and between pregnant and 
non-pregnant animals. The lack of differences in SAA concentration between males and females, 
3 
 
and pregnant and non-pregnant animals allowed us to establish the SAA RIs using samples from the 
whole population instead of establish partitioned RIs .Moreover, a stability in SAA concentration in 
serum samples with long storage time was demonstrated. 
PON-1 activity was determined using 4 different substrates using enzymatic assays. The PON-1 
activity using paraoxon as substrate provided results with good. The PON-1 activity in the whole 
set of bottlenose dolphins samples was 6.7 ± 4.6 U/L. As for the concentration of SAA, no 
differences in PON-1 activity were noted, based on sex, and between pregnant and non-pregnant 
animals. On contrary, the PON-1 activity for the long storage samples was significantly lower 
compared to the short storage samples. To evaluate the genetic influence of the single nucleotide 
polymorphisms (SNPs) in the PON-1 activity, we sequenced the two most studied SNPs of human 
PON-1 gene, the Q192R and the L55M. Based on the sequence analysis, all the dolphins were 
homozygous for methionine in L55M SNPs and for arginine in Q192R SNPs. Despite all the 
animals are homozygous for the phenotype associated to a higher paraoxonase activity in humans, 
the bottlenose dolphins’ PON-1 activity is low and it seems not useful to discriminate between 
healthy and diseased animals. The PON-1 activity using 4-nitrophenyl acetate (4-nPA) as substrate 
was higher compare to those obtained using paroxon, providing results with good precision and 
accuracy but no significant difference were noted between healthy dolphins and diseased dolphins. 
However, our results are based on a limited number of animals so we cannot exclude that, including 
a higher number of animals with different diseases, a more drastic change in PON activity will be 
evident. 
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1. INTRODUCTION 
1.1 Acute phase response 
The first reaction of the organisms to different pathological conditions is an innate, aspecific 
response that precede specific immune response (Gruys et al., 2005). The term ‘acute phase 
response’ (APR) is referred to a nonspecific and complex reaction of an organism that occurs 
shortly after any tissue damage (Cerón et al., 2005). Conversely from the specificity of cellular and 
humoral immunity, the changes induced by APR are non-specific and occur in response to several 
conditions (Jaye and Waites, 1997) such as infection, trauma, neoplasia, inflammation, and stress 
(Cray, 2012). The systemic reaction of APR includes neurological, endocrine, and metabolic 
perturbations. The consequence of these perturbations are fever, leucocytosis, increased release of 
several hormones, activation of the clotting, complement and kinin-forming pathways, and drastic 
rearrangement of plasma protein synthesis (Koj, 1996). Macrophages, blood monocytes, and 
dendritic cells localized in the site of tissue damage are the cells primarily involved in the starting 
of APR (Cassatella, 1995). These cells are activated when particular chemical structures in 
damaged tissue or infectious agents are presented for detection (Cassatella, 1995). At least 15 
different cytokines, secreted by activated leukocytes and other cells, are involved in APR (Gruys et 
al., 2005). These cytokines are classified in three groups, based on the effect pathways: (1) 
cytokines that primarily act as positive or negative growth factor for a variety of cells (IL-2, IL-3, 
IL-4, IL-7, IL-10, IL-11, IL-12, and granulocyte-macrophage stimulating factor); (2) cytokines with 
pro-inflammatory properties (TNF-α, TNF-β, IL-1 α, IL-β, IL-6, IFN α, IFN-γ, IL-8, and 
macrophage inhibitory protein-1); and (3) factors with anti-inflammatory activity (IL-1 receptor 
antagonist, soluble IL-1 receptors, TNF-α binding protein, and IL-1 binding protein) (Gruys et al., 
2005).  
The APR is associated to some changes in the organism that can be measured with some laboratory 
tests: (1) a decrease of blood plasma low and high density lipoproteins-bound cholesterol and 
leukocyte numbers; (2) an increased values of ACTH and glucocorticoids; (3) an activation of the 
complement and blood coagulation system; (4) a decreased serum levels of calcium, zinc, iron, 
vitamin A, and α-tocopherol; and (5) a change in concentration of several plasma proteins, the acute 
phase proteins (APPs) (Dinarello, 1989, 1983; Gruys et al., 1994). Few hours after a pathogen 
stimulus, in the liver, a change in the protein synthesis’ pattern happens such as the increased 
synthesis of some proteins (positive APPs). Hepatic mRNA up-regulation for positive APPs is 
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associated with a decreased synthesis of normal blood proteins such as transthyretin, retinol binding 
protein, cortisol binding globulin, transferrin, and albumin, which represent the negative APPs 
(Blackburn, 1994; Dinarello, 1989, 1983; Gruys et al., 1994; Ingenbleek and Young, 1994; Kushner 
et al., 1981). The changes in blood plasma composition induced by APR are beneficial to the 
organism because they prevent microbial growth and they help the restoring of homeostasis (Gruys 
et al., 2006). Some APPs opsonize micro-organisms and activate complement, others scavenge 
cellular remnants and free radicals, or neutralize proteolytic enzymes (Gruys et al., 2006). 
1.2 Electrophoresis 
Serum protein electrophoresis (SPE) is the most reliable method to determine the distribution of 
serum protein fractions and it is considered, together with a basic hematological and biochemical 
profile, an essential step to evaluate the health status of animals, providing clinically useful 
information. The interpretation of kinetics of total protein and albumin and globulin fractions is 
receiving increased attention in domestic and wild animals in which a typical pathologic pattern 
could be identified in several diseases, such as inflammatory diseases. With SPE, it is possible to 
separate the serum proteins into 4-6 categories based on the protein’s feature to migrate through 
cellulose acetate or agarose gel in an electrical field. With SPE, the degree of migration toward the 
anode is based on the electrical charge of the proteins and their mass and shape. In the serum of 
domestic mammals, albumin it is a small and very anionic protein, thus for these reasons, it has the 
faster migration. Globulins are bigger than albumin, but their negative charges caused an anodal 
migration. Moreover, some immunoglobulins are large and positive charge, so they migrate toward 
the cathode or do not migrate. The pH of the electrophoresis medium affects the charge and 
consequently the migration of proteins (Stockham and Scott, 2008b). Electrophoresis using 
cellulose acetate allows recognizing 5-9 protein bands, whereas using agarose allows recognizing 
10-15 protein bands. A protein band may represent one protein or several proteins with the same 
migration pattern. With these techniques, it is possible to identify the album and five globulins 
regions: α1, α2, β1, β2, γ in most of the domestic mammals (Stockham and Scott, 2008b). Capillary 
zone electrophoresis (CZE) is an attractive alternative to the gel-based methods’ electrophoresis 
(Bossuyt, 2006) because CZE allows a better peak resolution compared to AGE and eliminates 
some of its artefacts (Wijnen and van Dieijen-Visser, 1996). CZE combines the separation 
principles of conventional electrophoresis with the advanced instrumental design of high-
performance liquid or gas chromatography and capillary technology (Wijnen and van Dieijen-
Visser, 1996). With CZE, the separation of the protein fractions occurs in free solution in a narrow-
bore fused silica capillary that is exposed to a high voltage. For this technique, an alkaline borate-
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based buffer (pH 10) is used because at alkaline pH, serum proteins are negatively charged because 
the net charge of the proteins depends on the isoelectric point and by the pH of the buffer (Bossuyt, 
2003). When voltage is applied, two forces act on the proteins. First, the proteins, that are 
negatively charged, are attracted toward the anode. Second, an electro-osmotic force is involved. 
The internal surface of the fused-silica capillaries is negatively charged when the electrolyte 
solution inside is at pH 10. For this reason, the cations of the solution near the capillary wall 
migrate toward the cathode, pulling electrolyte solution with them: this is the electro-osmotic flow 
(Bossuyt, 2006). These two forces act in opposite directions and in CZE, the force of the electro-
osmotic flow surpasses the force of the electrical field so all proteins are carried toward the cathode 
(Bossuyt, 2006). Prealbumin and albumin are more resistant to the electro-osmotic flow than the γ-
globulins because they are more acidic. Therefore, prealbumin and albumin are the last to reach the 
cathode. The proteins are detected and quantified at the cathodal end of the capillary by 
measurement of the absorbance at 200 to 214 nm (Bossuyt, 2006). The absorbance at 200-214 nm is 
directly proportional to the number of peptide bonds and the borate buffer does not interfere with 
the UV detection (Bossuyt, 2006). With CZE it is possible to identify the albumin and 4 fractions of 
globulins referred to as α1, α2, β, γ globulins (Bossuyt, 2003). With serum protein electrophoresis, it 
is not possible to identify the amount of a single protein but rather the amount of a group of proteins 
with the same electrophoretic mobility (Cray et al., 2009). The APPs are contained in the globulins 
fractions: α globulins include α1-antitrypsin and α1–acid glycoprotein (AGP), and haptoglobin (Hp); 
β-globulins include transferrin, serum amyloid-A (SAA), and γ-globulins are composed primary by 
IgG, even if also C-reactive protein (CRP) is present (Johnson et al., 1999; Stockham and Scott, 
2008b). 
1.3 Acute phase proteins 
Recently, in the small animal medicine, studies on the role of APPs as markers of infectious, 
inflammatory and neoplastic diseases have proliferated (Eckersall and Schmidt, 2014) and at least 
40 different plasma proteins have been identified as APPs (Schrödl et al., 2016). Not only the 
‘classical APPs’ increase during APR, but also other non-protein molecules such as total serum 
sialic acid (Gopaul and Crook, 2006) or other proteins such as the APR-inducing cytokines or the 
hormones ghrelin, leptin, and gonadotropins (Maruna et al., 2005; Owen-Ashley et al., 2006). For 
this reason, in 2008, it has been proposed to replace the term ‘acute phase proteins’ with the term 
‘acute phase reactant’ (Paltrinieri, 2008). In the present thesis, our efforts were focused in the 
validation of the classical APPs, for this reason we used the term ‘acute phase proteins’ instead of 
‘acute phase reactants’.  
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APPs are a group of blood proteins that change in concentration in animals subjected to external or 
internal challenges, such as infection, inflammation, surgical trauma or stress (Murata et al., 2004). 
APPs are synthesized primarily by hepatocytes (Cray et al., 2009) stimulated by cytokines (Petersen 
et al., 2004) or endogenous glucocorticoids (Paltrinieri, 2008). The APPs are components of the 
non-specific innate immune response, and their concentration in the blood are proportional to the 
severity of the disorder and/or the extent of tissue damage (Murata et al., 2004). APPs are classified 
based on the direction of changes in positive APPs, when their synthesis is upregulated and the 
concentration in blood increase, or in negative APPs when their synthesis is downregulated and the 
concentration in blood decrease, after a pathogen stimulus (Schrödl et al., 2016). Positive APPs are 
further classified as major, moderate or minor based on the magnitude of increase during the APR: 
major APPs showed an increase of 10- to 100-fold, moderated APPs showed an increase of 2- to 
10-fold, and minor APPs have only a slight increase (Cerón et al., 2005). Moreover also the velocity 
of the concentration’s increase vary between major, moderate, and minor positive APPs: major 
APPs usually have a marked increase within 48 hours after a pathogen stimulus and often have a 
rapid decline after the cease of the pathogen stimulus due to their short half-life (Johnson et al., 
1999). Moderate and minor APPs usually increase more slowly but their increased concentration is 
more prolonged in duration. For this reason, moderate and minor APPs are usually detected 
increased during chronic inflammatory process (Cerón et al., 2005). The major, moderate, and 
minor APPs are different between species (Kent, 1992). For example, the major APP in ruminants 
is Hp (Conner et al., 1989); the major APP in dogs and men is CRP (Bürger et al., 1992; Eckersall 
et al., 1991; Pepys and Baltz, 1983); the major APP in horse is SAA (Pepys et al., 1989); the major 
APP in cats is AGP (Paltrinieri, 2008); and the major APPs in pigs are Hp, SAA, and major acute 
phase protein (MAP) (Petersen et al. 2004).  
The CRP is named for its binding capacity to pneumococcal somatic C-polysaccharide. CRP is 
synthetized by the hepatocytes, it has a molecular size of approximately 115 kDa and consists of 
five non covalently associated polypeptides subunits (Pepys and Baltz, 1983). It is a member of the 
highly conserved pentraxin protein family and contributes to innate immunity against infection and 
to handling of autologous ligands, probably helping to prevent development of autoimmunity. The 
autologous ligands of CRP include phospholipids and ribonucleoproteins from necrotic and 
apoptotic cells (Thompson et al. 1999). The human SAA is has a molecular size of approximately 
180 kDa (Pepys and Baltz, 1983) since SAA is normally found in a complex with lipoproteins 
(Petersen et al., 2004). The molecular size of SAA decrease after denaturation, and the molecular 
size of the denaturated SAA is between 9 and 14 kDA in different species (Hultén et al., 1997; 
Nunokawa et al., 1993; Pepys and Baltz, 1983). Serum paraoxonase-1 (PON-1) is synthetized 
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primarily by the hepatocytes and a portion is secreted into the plasma, where it is associated with 
high density lipoprotein (HDL) (Costa et al., 2005). The name PON-1 is given by one of the most 
substrate used for the evaluation: paraoxon, the toxic metabolite of the insecticide parathion. 
However, PON-1 hydrolyzes the active metabolites of several other organophosphorus insecticides, 
as well as nerve agents such as sarin, soman and VX (Draganov et al., 2004). Based on the several 
functions of PON-1, several substrates can be used to evaluate the different activities of this 
enzyme. 
The use of APPs as marker of homeostasis’ perturbation provides some advantages compared with 
the leukocyte count. The diagnostic sensitivity of APPs is higher (Kjelgaard-Hansen et al., 2003); 
the stability of APPs in serum/plasma samples is higher than the cellular components of blood, so it 
is possible to measure APPs in frozen serum/plasma samples (Solter et al., 1991); the change in 
APPs concentration is faster than changes in WBC counts (Kjelgaard-Hansen et al., 2003). One 
limitation of the APPs is the poor diagnostic specificity, for this reason they cannot be used as 
primary diagnostic test for a particular disease (Cerón et al., 2005). The APPs were successfully 
used to detect subclinical diseases and to monitor clinical evolution and to assess response to 
treatment (Cerón et al., 2005). In dogs an increase of APPs was demonstrated in cases of infectious 
diseases (Yamamoto et al., 1994), surgery (Christensen et al., 2015; Yamamoto et al., 1993), 
gastrointestinal disease (Otabe et al., 2000), autoimmune diseases (Caspi et al., 1987), endocrine 
diseases (McGrotty et al., 2003; Sasaki et al., 2003), and neoplasia (Caspi et al., 1987; Yuki et al., 
2011). In addition, a correlation has been described between APPs levels and the severity of disease 
(Matijatko et al., 2007; Rikihisa et al., 1994; Yamamoto et al., 1994; Yule et al., 1997). Moreover, 
the measurement of APPs is proposed also as a test for liver function because, in end-stage liver, 
there is a decrease in the production of APPs (Kent, 1992). The combined measurement of several 
APPs provides more information than the evaluation of a single protein. In 2006 Gruys and 
colleagues proposed the ‘APP value index’ in which a major and moderate positive APPs are 
combined to a major and moderate negative APPs (Gruys et al., 2006). This index was used as 
prognostic factor in human patients with multiple myeloma (Dupire et al., 2012) and as acute phase 
index in pigs (Toussaint et al., 1995).  
1.4 Infectious diseases of marine mammals 
The cetaceans are primarily or secondary affected by several diseases.  
Different cetacean’s species are susceptible to distemper-like diseases due to cetacean morbillivirus 
(CeMV). CeMV consists of three strains: the porpoise morbillivirus (PMV), the dolphin 
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morbillivirus (DMV), and the pilot whale morbillivirus (PWMV) (Van Bressem et al., 2014). PMV 
and DMV are closely related each other, and are more closely related to the ruminant 
morbilliviruses and measles virus than to the distemper virus (Osterhaus et al., 1995). Most of the 
morbilliviruses are lymphotropic and epitheliotropic (Osterhaus et al., 1995). The first site of 
replication is the lymphoid tissues, after the infected lymphocytes carries the virus through the 
lymphatic system to the epithelial cells, which are infected (Delpeut et al., 2014; Ludlow et al., 
2015). The lesions in the acute fatal infection are multifocal to diffuse interstitial broncho-
pneumonia, necrosis of type 1 pneumocytes and bronchiolar epithelial cells, interstitial oedema, 
hyperplasia of type 2 pneumocytes, and formation of large syncytia in the alveolar and bronchiolar 
lumina. Intracytoplasmatic and intranuclear inclusion bodies can be present in the affected cells. 
The lymphoid tissues are characterized by lymphoid depletion and necrosis of the germinal centres, 
with the presence of syncytial cells (Van Bressem et al., 2014). If the animals survive the acute 
infection, they may succumb to opportunistic infections such as Toxoplasma gondii, herpesviruses, 
bacteria, and fungi due to immunosuppression. The typical lesions of the acute infection can be 
absent or obscured by the inflammation secondary to the opportunistic pathogens. The lesion 
indicative of sub-acute infection is a non-suppurative demyelinating meningoencephalitis, often 
focally distributed (Van Bressem et al., 2014). The animals that survive to the acute and sub-acute 
infection can succumb later because of the secondary infections, or from complications of CNS 
infection. The cause of the death is usually multifactorial (Van Bressem et al., 2014). Lesions and 
virus in the brain can be detected in the animals that survived the DMV systemic infection 
(Domingo et al., 1995; Ludlow et al., 2015; Soto et al., 2011). The lesions of the brain form are 
localized mostly in the cerebral cortex, the subcortical white matter, and the thalamus (Domingo et 
al., 1995), where it is possible to identify morbilliviral genome and/or antigens (Di Guardo and 
Mazzariol, 2016). The histological lesions noticed are similar to the lesions described in the 
subacute sclerosing panencephalitis (Garg, 2008) and in the old dog encephalitis (Headley et al., 
2009). The DMV infection is the only variant that is associated to the ‘brain only form’ (Van 
Bressem et al., 2014). 
Papillomaviruses are epitheliotropic viruses. The infection induces the proliferation of the 
epithelium of skin and mucosae causing warts, papillomas, and condylomas (Howley and Lowry, 
2001). Three type of papillomaviruses, named type 1, type 2, and type 3, are capable to induce 
genital papillomatosis in dolphins from Europe and Atlantic USA (Rector et al., 2008). It seems that 
the development of the lesions in affected animals is associated to immunosuppressive conditions 
(Antonsson and Hansson, 2002). 
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Cetacean poxviruses are the etiologic agents responsible of tattoo skin disease. This pathology is 
characterized by the presence of typical, irregular, grey, black or yellowish, stippled cutaneous 
lesions (Van Bressem et al., 2003). As for papillomavirus’s lesions, also the development of tattoo 
skin disease is associated to immunosuppressive status: juvenile animals or odontocetes in poor 
health conditions are more susceptible (Van Bressem et al., 2009). In healthy animals, the tattoo 
skin disease usually doesn’t have high mortality rate (Van Bressem et al., 2003), however it can kill 
neonates and calves without protective immunity (Van Bressem et al., 1999), and also the co-
infection with fungi or bacteria increases the mortality (Smith et al., 1983; Van Bressem et al., 
2003). 
Brucellosis is a zoonotic disease that affects reticuloendothelial, reproductive, musculoskeletal, and 
cutaneous system. In humans, it is reported that can cause generalized infection and septicaemia 
(Corbel, 1997). Three species of Brucella have marine mammals as preferred host: Brucella 
delphini for dolphins, Brucella phocoenae for porpoises, and Brucella pinnipedialis for seals 
(Foster et al., 2007; Groussaud et al., 2007). The transmission can be both horizontal and vertical 
(Van Bressem et al., 2009). The inflammatory lesions are localized in placenta with consequent 
aborts, testes, mammary gland, lung, sub-cutis, joints, liver, spleen, lymph nodes, and central 
nervous system (Corbel, 1997; Dagleish et al., 2008; Davison et al., 2009; Foster et al., 2007, 2002; 
González et al., 2002; Groussaud et al., 2007). The inflammation in central nervous system and the 
consequent damages may induce stranding of animals (Davison et al., 2009; Hernández-Mora et al., 
2008). 
Toxoplasma gondii is an obligate intracellular protozoan parasite that can infest marine mammals as 
intermediate hosts (Dubey et al., 2003; Miller et al., 2008), even if only cats and wild felids are the 
definitive hosts. Animals, usually immunosuppressed due to morbillivirus infection or other 
immunosuppressive diseases (Di Guardo et al., 1995), can be infected by ingestion of contaminated 
food/water or transplacentally (Van Bressem et al., 2009). The inflammatory lesions are usually 
located in lymph nodes, adrenal glands, myocardium, lungs, central nervous system (Van Bressem 
et al., 2009). 
1.5 Evaluation of cellular and humoral immune responses in marine 
mammals 
Increasing knowledge in cellular and humoral immune response is a fundamental step in 
understanding the relationship between infectious pathologies and the immune system in marine 
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mammals. From 1978, different assays were proposed to evaluate the cellular and humoral immune 
response. 
The lymphocyte transformation assay allows the qualitative and quantitative evaluation of non-
specific and antigen-specific cellular immune response. Several protocols have been proposed in the 
past years. In 1978 Colgrove demonstrated in vitro that concavalin A (Con A) induced the most 
intense lymphocyte proliferation compared to phytohemagglutinin (PHA) and pokeweed mitogen 
(PWM) (Colgrove, 1978). However inter-individual differences of white blood cells and the 
inhibitory effect of elevated blood cortisol levels during transportation or handling of animals 
hindered the standardization of lymphocyte transformation assay (De Guise et al., 1996; Noda et al., 
2006). For these reasons, it was proposed to isolate the leukocytes, with different techniques such as 
density gradient centrifugation. The isolated leukocytes are successfully stimulated by Con A, PHA, 
and PWM, while the B cell mitogen lipopolysaccharide fails to induce detectable proliferation 
(Lahvis et al., 1993). 
Natural killer (NK) cells plays an important role in innate immunity against viral infections. To 
evaluate the role of these cells, chromium release assay and detection of necrotic cells by flow 
cytometry have been validated (Beineke et al., 2010). The phagocytosis and generation of reactive 
oxygen species represent other defence mechanisms of innate immunity. The kinetics of these 
leukocyte functions, particularly in vitro ingestion of latex beads and hydrogen peroxide production 
have been evaluated in beluga whales and in bottlenose dolphins using flow cytometry (De Guise et 
al., 1996; Noda et al., 2003). 
The superoxide generation of neutrophils of bottlenose dolphins is upregulated by 
phorbolmyristicacetate in vitro and the incubation with superoxide dismutase causes a dismutation 
of oxygen radicals in cultured dolphin leukocytes (Noda et al., 2003; Shiraishi et al., 2002). 
Immunoglobulin (Ig)A, IgG, and IgM have been purified or identified in the plasma of dolphins and 
whales by cross-reacting markers (Andrésdóttir et al., 1987; Cavagnolo, 1979; Nash and Mach, 
1971; Travis and Sanders, 1972). Moreover cDNA of the heavy chains of IgA, IgG and IgM coding 
genes of the bottlenose dolphin have been cloned and sequenced (Lundqvist et al., 2002; Mancia et 
al., 2007, 2006). To investigate serum Ig levels by radial immunodiffusion assay and by ELISA, 
species-specific antibodies against cetacean IgG have been produced (Nollens et al., 2007; Ruiz et 
al., 2009; Taylor et al., 2002). 
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1.6 Evaluation of cytokines in marine mammals 
In addition, the investigation of cytokine expression and acute phase responses give important 
information about the functionality of lymphoid cells in marine mammals. Also the use of 
recombinant cytokines enables the production of specie-specific antibodies for developing 
immunological assays and to study the possible therapeutic application in whales and dolphins 
(Denis and Archambault, 2001; Manire and Rhinehart, 2000; St-Laurent and Archambault, 2000).  
Quantification of cytokine expression enables the investigation of leukocyte functionality and 
characterization of inflammatory response (Beineke et al., 2010). IL-1α, IL-1β, and IL-1 receptor 
antagonist (ra) cDNA have been cloned and sequenced from mitogen-stimulated leukocytes of 
bottlenose dolphins (Beineke et al., 2010). The receptor binding of IL-1 is highly conserved, while 
the remaining structure have a minor degree of homology (Beineke et al., 2010). To assess the 
cellular immune response in bottlenose dolphins an IL-2 receptor expression assay was developed 
(Erickson et al., 1995) and the mRNA of the IL-2 precursor molecule of the beluga whales was 
cloned and sequenced (St-Laurent et al., 1999). In bottlenose dolphins it was demonstrated also the 
existence and the function of the pro-inflammatory cytokines tumour necrosis factor (TNF)-α (St-
Laurent et al., 1999). In 1996 King et colleagues demonstrated a conserved biological activity of the 
cytokine in different terrestrial and aquatic mammal species (King et al., 1996). Moreover the 
coding regions of the IL-1β, IL-6, and TNF-α gene of the beluga whale have been sequenced, and 
the cytokine-specific rabbit antisera have been produced (Denis and Archambault, 2001; St-Laurent 
and Archambault, 2000). In harbour porpoise the detection and quantification of mRNA of IL-1β, 
IL-2, IL-4, IL-6, IL-10, and TNF-α have been performed by PCR (Beineke et al., 2004), and the 
increase of IL-10 was seen in harbour porpoises suffering from long lasting infectious (Beineke et 
al., 2007). The identification of IL-2, IL-4, IL-10, IL-12, IL-13, IL-18, TNF-α, TGF-β , and 
interferon (IFN)-γ was performed using RT-PCR in bottlenose dolphins, pacific white-sided 
dolphins, and beluga whales (Sitt et al., 2008). 
1.7 Acute phase reaction in marine mammals 
The evaluation of health status of marine mammals is difficult because the classical clinical signs of 
illness used for human and domestic animals are difficult to recognize or of difficult interpretation. 
For this reason, in the past years, several efforts were done to identify laboratory markers of disease 
in these animals. First markers tested were white blood cell counts, erythrocyte sedimentation rate, 
and body temperature (Bossart et al., 2001). However, a change in these parameters are not seen in 
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early stage of diseases. For this reason, efforts are direct at identifying inflammation at earlier stage 
(King et al., 2001). The APPs have demonstrated their role as early markers of inflammation in both 
human and veterinary medicine, so based on the results obtained in humans and companion 
animals, several positive APPs were tested in marine mammals while no information are available 
for negative APPs. One limitation in the application of APPs in marine mammals is the lack of 
specie-specific Abs, moreover the knowledge about APP in one species cannot be readily 
extrapolated to another species, in which healthy levels, response to inflammation or infection, and 
diagnostic and prognostic potential may be different (Kjelgaard-Hansen et al., 2011). In bottlenose 
dolphins (Tursiops truncatus) three APPs (CRP, SAA, and Hp) were tested, even if not always 
complete validation study was performed (Cray et al., 2013; Segawa et al., 2013); in florida 
manatees (Trichechus manatus latirostris) five different APPs were tested: AGP, CRP, Hp, 
fibrinogen, and SAA (Harr et al., 2006); in harbor seals (Phoca vitulina) Hp and CRP were tested 
(Funke et al., 1997; Kakuschke et al., 2010; Rosenfeld et al., 2009). The aims of these studies were 
to evaluate the feasibility of the assays to measure the APPs and to determine the RIs. In bottlenose 
dolphins, the authors established the RIs for the three APPs (Cray et al., 2013) and demonstrated 
that Hp levels in the serum increase under inflammatory conditions (Segawa et al., 2013). In the 
florida manatee, SAA was the APP with the highest diagnostic sensitivity and specificity (90% for 
both sensitivity and specificity) in the detection of inflammatory diseases, the diagnostic specificity 
of Hp and fibrinogen were 93% and 95% respectively while the diagnostic sensitivity for these two 
APPs were 60% and 40% respectively. The Abs used for the determination of the concentration of 
AGP and CRP did not cross-react in this specie (Harr et al., 2006). In the harbor seals, an Ab to 
identify the CRP was produced (Funke et al., 1997) and the Hp was demonstrated to be a sensitive 
marker of the health/disease status (Kakuschke et al., 2010). 
1.8 Validation process 
The major steps in the establishment of reference intervals are 
1. Select criteria for reference individuals 
2. Establish a reference sample group 
3. Collect and process the samples 
4. Determine the reference values 
5. Determine the reference distribution 
6. Determine the reference limits and reference intervals (Stockham and Scott, 2008a). 
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The analytical properties of one assay are five: analytical precision, analytical accuracy, analytical 
specificity, detection limit, and analytical sensitivity. 
 ANALYTICAL PRECISION is the ability of an assay to get the same result if a sample is 
analyzed several times and it is frequently expressed in clinical laboratories by the 
coefficient of variation (CV) of the method. The CV is expressed as a percentage and it is 
calculated by this formula: (standard deviation/mean)*100. The CV is determined from 
replicate analysis within an assay run (intra-assay CV) and between different runs of the 
same assay (inter-assay CV). The intra-assay CV is the expected error (Stockham and Scott, 
2008a). 
 ANALYTICAL ACCURACY represents the closeness of the agreement between the 
measured value of an analyte and its ‘true value’. To determine the analytical accuracy it is 
possible to compare the values obtained by the ‘new’ assay to the values obtained by the 
reference method or it is possible to use standard solutions (Stockham and Scott, 2008a). 
 ANALYTICAL SPECIFICITY is the ability of an assay to detect only the substance of 
interest (Stockham and Scott, 2008a). 
 DETECTION LIMIT represent the smallest concentration or quantity of an analyte that can 
be detected with reasonable certainty. It represents the ability of one assay to discriminate 
the ‘background noise’ from a true change because of the presence of an analyte (Stockham 
and Scott, 2008a). 
 ANALYTICAL SENSITIVITY is how much change of the analyte is needed for the assay 
to detect the change (Stockham and Scott, 2008a). 
After the analytical validation of a new assay, it is important to determine how likely if a 
laboratory test result is outside the RIs, the animal has a certain disorder and if a laboratory test 
resultis within the RIs, the animal does not have a certain disease or pathologic state. This 
evaluation is called ‘diagnostic validation’. The test results can be classified as true positive, 
true negative, false positive, and false negative. After the test results are classified as true 
positive, true negative, false positive, or false negative, it is possible to determine the diagnostic 
sensitivity, the diagnostic specificity, the diagnostic accuracy, the predictive value of positive 
test, and the predictive value of negative test (Stockham and Scott, 2008a). 
 DIAGNOSTIC SENSITIVITY is the probability that a test results positive in diseased 
animals. The diagnostic sensitivity must be high in the screening test. To calculate the 
diagnostic sensitivity the formula is (true positive/(true positive + false negative))*100 
(Stockham and Scott, 2008a). 
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 DIAGNOSTIC SPECIFICITY is the probability that a test results negative in non-
diseased animals. A test with high diagnostic specificity is used to confirm a positive 
result obtained with a screening test (test with high diagnostic sensitivity). To calculate 
the diagnostic specificity the formula is (true negative/(true negative + false 
positive))*100 (Stockham and Scott, 2008a). 
 DIAGNOSTIC ACCURACY is the frequency with which a test correctly classifies an 
animal as having or not having the disease. To calculate the diagnostic accuracy the 
formula is (true positive + true negative/(true positive + true negative + false positive + 
false negative))*100 (Stockham and Scott, 2008a). 
 PREDICITVE VALUE OF A POSITIVE RESULT is the probability that a positive test 
result indicates that the animal has the disease. To calculate the predictive value of a 
positive result the formula is (true positive/(true positive + false positive))*100 
(Stockham and Scott, 2008a). 
 PREDICITVE VALUE OF A NEGATIVE RESULT is the probability that a negative 
test result indicates that the animal does not have the disease. To calculate the predictive 
value of a positive result the formula is (true negative/(true negative + false 
negative))*100 (Stockham and Scott, 2008a). 
RECEIVER OPERATING CHARACTERISTIC (ROC) CURVES display the relationship 
between a true positive rate and a false positive rate. ROC curves can be used to compare the 
diagnostic accuracy of assays and to establish a decision threshold to rule in or rule out a 
diagnosis. To compare the diagnostic accuracy of different assays it is possible to visually 
analyse the ROC curves or to calculate the area under the ROC curves of the different assays 
(Stockham and Scott, 2008a). 
Results of laboratory tests on patient samples would be very difficult to interpret without reference 
intervals (RIs). RIs are an integral component of laboratory diagnostic testing and clinical decision-
making and represent the estimated distribution of reference values from healthy populations of 
comparable individuals (Friedrichs et al., 2012). RIs usually comprised the 95% of a healthy 
reference population, and the criteria used to establish health (selection or inclusion criteria) should 
be established (Friedrichs et al., 2012). The confidence intervals (CI) is an estimation of the 
uncertainty of the limits and is generally narrower for large sample sizes (Friedrichs et al., 2012). 
To determine RIs using non parametric methods with 95% CI, a minimum of 120 individuals is 
recommended. In this case the 2.5th fractile serves as lower reference limit and the 97.5th fractile as 
upper reference limit (Horn and Pesce, 1983). If fewer than 120 samples are available, alternative 
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methods are required to determine 95% CI. For example, robust methods are recommended when 
the reference samples are ≥ 40 and ≤ 120 (Horn et al., 1998), but also parametric methods can be 
used when the reference samples are ≥ 40 and ≤ 120 if the data have or can be transformed to 
Gaussian distribution (Friedrichs et al., 2012). When the reference samples are ≥ 20 and ≤ 40, RI 
should be calculated by methods that are robust or parametric, but to highlight the incertainty, 90% 
CI should be calculated (Friedrichs et al., 2012). If the reference samples are ≤ 20 RI should not be 
determined and it is better to report a table of ascending values along with histogram and mean or 
median values (Friedrichs et al., 2012). 
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2. AIMS 
In order to increase the knowledge on inflammatory markers and to provide more sensitive tools to 
evaluate health status in odontocetes, we focused our work on two main topics: serum protein 
electrophoresis (SPE) and acute phase proteins (APPs). Thus, the present thesis is dived in two 
chapters: the first chapter is focused on the generation of RIs for SPE in under human care 
bottlenose dolphins, on the identification of bisalbuminemia and on the evaluation of the genetic 
bases of this disorder; while the second chapter is focused on the evaluation of APPs in dolphins. 
More in detail, in order to increase the knowledge on SPE, the aims of the first chapter were: 
 To establish the RIs for serum protein fractions evaluated with agarose gel electrophoresis 
(AGE) in bottlenose dolphins kept under human care. 
Since AGE electropherogram of some dolphins showed a wider base of the albumin peak, all 
the animals were investigated also with CZE, in order  
 To report the presence of bisalbuminemia and to evaluate the sensitivity and specificity of 
AGE in the diagnosis of this disorder compared to CZE.  
 To investigate the polymorphisms in the albumin gene in two families of bottlenose 
dolphins in which bisalbuminemia was found.  
 To identify the mutations responsible for bisalbuminemia and to identify the inheritance 
pattern of this condition in two families of bottlenose dolphins. 
In the present work, two positive APPs: CRP and SAA, and one negative APP, the PON-1 were 
studied. The aims of the second chapter were: 
 To assess the cross-reactivity of commercially available anti-human and anti-canine 
antibodies (Abs) used in immunological automated assays for SAA and CRP in striped 
dolphins (Stenella ceoruleoalba) and bottlenose dolphins (Tursiops truncatus). 
 To validate automated assays for the measurement of SAA and CRP in bottlenose dolphins. 
 To validate methods to measure PON-1 with different substrates, identify the one(s) more 
suitable to use in bottlenose dolphins, and to define the RIs. This part of the project was 
partially carried out in Murdoch University, Perth, Western Australia. 
 To identify the presence of single nucleotide polymorphisms (SNPs) in the PON-1 gene, and 
to evaluate if the SNPs can influence the PON-1 activity. 
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3. MATERIALS AND METHODS 
Since the present study has two different chapters, named ‘serum protein electrophoresis, and ‘acute 
phase proteins’, this section has been divided in two main paragraphs to give better details on the 
methodology used. 
3.1 Serum Protein Electrophoresis 
3.1.1 Establishment of reference intervals for serum protein fraction in bottlenose 
dolphins 
Animals and samples 
Serum samples from bottlenose dolphins with normal clinical history, physical examination and 
complete haematological and biochemical exams were used. The exclusion criteria were: diseased 
animals, clinically healthy animals with abnormality in the haematological and biochemical exams 
and animals that are receiving medical treatment. A total of 38 dolphins were enrolled: 20 dolphins 
were males and 18 females. The median age was 18 years, minimum 1 year, maximus 51 years. 
They were housed in Acquario di Genova (14 animals), Oltremare in Riccione (11 animals), 
Mediterraneo Park in Malta (8 animals), and Zoomarine Italy (7 animals). Peripheral blood samples 
were obtained from individual animal during the veterinary procedures to evaluate health status of 
the animals. The animals were housed and handled in agreement with the Italian and Maltese Zoo 
directive law (DL 73/2005 and S.L.439.08 respectively) and all the samples were obtained 
according to D.M. 469/2001, which establishes the management objectives and prescriptions to 
maintain the species Tursiops truncatus under human care. Blood was collected in plain tubes; 
serum was obtained by centrifugation of blood samples at 1500g for 10 minutes. All serum samples 
were visually inspected and were not grossly hemolyzed or lipemic; thus, all samples were stored at 
-20°C until analysis. 
Agarose gel electrophoresis 
AGE was performed as already described (Giordano and Paltrinieri, 2010) using an automated 
system and kits provided by the manufacturer of the instrument (Sebia Italia Srl, Bagno a Ripoli, 
Firenze, Italy). Briefly, a 0.8% agarose gel was run in Trisbarbital buffer at pH 8.5, with migration 
time of 7 minutes at 800 V. Gels were stained with amido Schwarz, destained, and dried for 
scanning by the appropriate gel scanner. Data where then transferred to the software program and 
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visually inspected to correct the possible errors in fractions separation generated by the automated 
software (Phoresis, Sebia Italia Srl, Bagno a Ripoli, Firenze, Italy). 
Total protein  
Total protein (TP) concentration was determined by the biured method on an authomated 
spectrophotometer (Cobas Mira, Roche Diagnostics, Basel, Switzerland), and absolute values for 
each electrophoretic fraction were calculated based on TP and percentage of the fraction. 
Data analysis  
The RIs were obtained using an Excel spreadsheet with the Reference Value Advisor (v.2.1) set of 
macroinstructions as reported by Geffré and colleagues (Geffré et al., 2011). The software performs 
the computations recommended by the International Federation of Clinical Chemistry-Clinical and 
Laboratory Standards Institute (2008) such as the descriptive statistics (mean, median, standard 
deviation (SD), minimum and maximum values), the tests of normality (Anderson–Darling with 
histograms and Q–Q plots and Box–Cox transformation) and the outlier analysis. Both Dixon–Reed 
and Tukey tests were used, and outliers classified as ‘suspected’ were retained, as recommended by 
the ASVCP guidelines (Friedrichs et al., 2012). RIs were calculated using standard and robust 
methods on both non-transformed and transformed data. The software indicates the best method to 
define the RIs based on data distribution. A non-parametric bootstrap method was used to calculate 
the 90% confidence interval. 
For the intra-assay and inter-assay repeatability of AGE, a pooled dolphin’s serum sample was 
used. 
3.1.2 Identification of bisalbuminemia 
Animals and samples 
For the identification of bisalbuminemia and to evaluate the diagnostic sensitivity and specificity of 
the AGE in comparison to CZE in the diagnosis of this disorder, the same serum samples used in 
the ‘Establishment of reference intervals for serum protein fraction in bottlenose dolphins’ chapter 
were used. 
Agarose gel electrophoresis 
The AGE was performed as described in the ‘Establishment of reference intervals for serum protein 
fraction in bottlenose dolphins’ chapter. 
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Capillary Zone Electrophoresis 
CZE was performed with the MINICAP system 6 kit by SEBIA (Sebia Italia Srl, Bagno a Ripoli, 
Firenze, Italy), designed for the separation of serum protein in alkaline buffer (pH 9.9) into four 
major fractions. The MINICAP performed all analysis automatically to obtain a protein profile for 
qualitative and quantitative analysis. A sample diluted with buffer was prepared and injected by 
aspiration at the anodic end of the capillary. A high voltage protein separation was then performed 
and direct detection of the proteins was made at 200 nm at the cathode end of the capillary. The 
instrument recorded the absorbance corresponding to each electrophoretic fraction and sent the data 
to the software (Phoresis, Sebia Italia Srl, Bagno a Ripoli, Firenze, Italy), which converted the 
absorbance in peaks. The capillaries were immediately washed with a wash solution and prepared 
for the next analysis with buffer. The electrophoretograms were interpreted visually to screen for 
any pattern abnormality. 
Electrophoretic profiles obtained with CZE and AGE were firstly visually analyzed to identify the 
presence of a double peak in the albumin region. Since only an apparently wider albumin peaks 
were noted in some AGE electrophoretic profiles, the ratio between base and height (b/h) of the 
albumin peak was calculated and each point-value recorded in the whole data set was used to 
calculate the ROC curve and to define the ‘ideal’ cut-off value able to identify this abnormality in 
AGE electrophoresis. For this analysis, the true positive samples were considered those with a 
double peak in CZE.  
The difference in TP, albumin percentage and absolute value between bisalbuminemic and normal 
animals was evaluated by Mann-Whitney test while the differences between the albumin percentage 
obtained by CZE and AGE were analyzed with a Wilcoxon signed-rank test for paired data. All 
statistical analysis was performed using standard statistical software (IBM SPSS Statistics 22.0). 
3.1.3 Genetic bases of bisalbuminemia 
Animals and samples 
A total of 15 animals from two distinct families (nine from family A and six from family B) were 
used. Five animals in family A (Tt5, Tt6, Tt7, Tt8, Tt9) and two animals in family B (Tt10, Tt14) 
were known to be bisalbuminemic based on CZE analysis. Four animals, in both family A (Tt1, 
Tt2, Tt3, Tt4) and in family B (Tt10, Tt11, Tt12, Tt13) were wild founders, while all the other 
dolphins (Tt5, Tt6, Tt7, Tt8, Tt9 in family A; Tt14, Tt15 in family B) were born under human care. 
The animals were permanently housed in aquaria and dolphinaria (Acquario di Genova and 
Oltremare, Italy, and Mediterraneo Park, Malta) under conditions approved by Italian and Maltese 
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laws (Italy: Zoo directive DL 73/2005, and DM 469/2001; Malta: Zoo directive 94 S.L.439.08 and 
the European Association of Aquatic Mammals (EAAM) 2009 ‘’Standards and Guidelines for the 
Management of Bottlenose Dolphins (Tursiops sp) Under Human Care’’). 
Peripheral blood samples (10 cm3 collected into EDTA for haematology) were collected in 
accordance with relevant guidelines and regulations: 13 animals were sampled from the ventral 
fluke veins during routine veterinary health examinations without restraint according to DM 
469/2001. Once used for the complete blood cell count exam, the remaining blood samples were 
used for DNA extraction. Two dolphins (Tt10, Tt11) had died prior to commencement of the study, 
thus archived frozen tissue obtained during the necropsy were used (liver for Tt10 and muscle for 
Tt11). 
DNA extraction 
Genomic DNA was extracted using QIAamp DNA Mini Kit (Quiagen, Milan, Italy) following the 
manufacturer’s instruction. Twenty microliters of proteinase K were added to 200 µl of each 
sample. Then, 200 µl buffer AL was added to the sample, mixed by pulse-vortexing for 15 seconds 
and incubated at 56°C for 10 minutes. Two hundreds µl of ethanol (96%-100%) were added to the 
samples and then carefully applied to the QIAamp Mini spin column in a collection tube without 
wetting the rim. The spin columns were centrifuged at 6000 x g for 1 minute and then placed in a 
clean collection tube and the tubes containing the filtrate were discharged. Carefully, 500 µl of 
buffer AW1 were added without wetting the rim and centrifuged at 6000 x g for 1 minute. QIAamp 
Mini spin columns were then placed in a clean tube, 500 µl of buffer AW2 were added and 
centrifuged at 20,000 x g for 3 minutes. Finally, the QIAamp Mini spin columns were placed in a 
clean tubes and 200 µl of distilled water were added. After incubation at room temperature for 1 
minute, the tubes were centrifuged at 6000 x g for 1 minute. Amount of DNA extracted from 
peripheral whole blood ranged from 10.4 ng/µl to 50.4 ng/µl, while DNA extracted from tissues 
ranged from 119.6 ng/µl (liver) to 362.8 ng/µl (muscle). 
Albumin gene mutation and gene reconstruction 
The structure of the bottlenose dolphin albumin gene was reconstructed by direct comparison of its 
full length cDNAs with the provisional sequence of bottlenose dolphin albumin gene (Gene ID: 
XP_004322082.1). The coding region of the albumin gene was screened for alterations by direct 
sequencing of all samples. Polymerase chain reaction (PCR) primers flanking each exon of the 
albumin gene were designed by PRIMER3 (http://www.genome.wi.mit.edu). PCR amplifications 
were performed in a final volume of 25 µl, containing 50-100 ng of genomic DNA, 5x Colorless 
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GoTaq® Reaction Buffer (Promega, Fitchburg, WI, USA), 400 nmol/L each primer, 100Mmol/L 
deoxinucleotide triphosphates (Invitrogen, Waltam, MA, USA), and 0.5 U of GoTaq® DNA 
Polymerase (Promega). PCR amplification for exon 10 was performed in a final volume of 25 µl, 
containing 50-100 ng of genomic DNA, 5x AS Reaction Buffer (Fisher Molecular Biology, Rome, 
Italy), 500 nmol/L MgCl2, 400nmol/L each primer, 100 Mmol/L deoxynucleotide triphosphates 
(Invitrogen), and 0.5 U of Taq DNA Polymerase (Fisher Molecular Biology). Cycling conditions 
(denaturations at 95°C for 30 seconds, annealing for 30 seconds, and extension at 72 °C for 45 
seconds) were repeated for 35 cycles. PCR primers and conditions are reported in table 3.1.3.A. 
Sequencing of the albumin gene was performed using the automatic sequencer 3130ABI PRISM 
Genetic Analyzer (Applied Biosystem, Foster City, CA, USA). Chromas 1.5 software 
(Technelysium, Suth Brisbane, Queensland, Australia) and LASERGENE package computer 
programs (DNASTAR, Madison, WI, USA) were used to edit, assemble, and translate sequence. 
The obtained albumin sequences were compared with reference sequence XP_004322082.1 and 
analyzed in order to identify non-synonymous and synonymous substitutions (variation in DNA 
sequences with or without change in amino acid sequences). For non-synonymous substitutions, the 
correlation between genotype and ‘’bisalbuminemic’’ phenotype was investigated with the pedigree 
of the two families, in order to identify both the mutation responsible for bisalbuminemia and the 
pattern of inheritance. 
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Table 3.1.3.A: Oligonucleotide primers used for PCR amplification and DNA sequencing of the 
exons of dolphin albumin gene. Abbreviation: TD, touch-down; bp, base pairs. 
Exons Forward Primer (5’- 3’) Reverse Primer (5’- 3’) Products 
size 
Annealing 
temperature 
Exon 1 agcgctgatctccctctatt ctcactattcgtttcacctagga 340 bp 55°C 
Exon 2 atcttggagcaaatgaatacct aaccagtaccattagaaacgtt 225 bp  55°C 
Exon 3 tctagcatagcaacctactgt gctatacccacttttgagcg 344 bp 55°C 
Exon 4 ggaaaacaaaagtctgccca tgtcattagaacagaagcttcaa 383 bp 58°C 
Exon 5 tggaggttctggggagaatgt ggggaaaagacggaggaagg 367 bp TD 70°C-60°C 
Exon 6 ggggtggtctgcgtaaaatt tgttactgatgctctggttttca 322 bp 60°C 
Exon 7 tgccctaagagaacaatttggt ctcaaaccactctcagttgttct 400 bp 55°C 
Exon 8 gaggaagcacagcaaagtca ggcaacatgaagattgtagcaa 372 bp 58°C 
Exon 9 ttgggagtgcggagacttag agcacagagttgaaaccatctt 369 bp 55°C 
Exon 10 gaaacacaacctgcatctgg agacccaaagcagccaaaa 300 bp TD 70°C-60°C 
Exon 11 cagtttcttgcctggctgaa acacacattagcccaccctt 282 bp 55°C 
Exon 12 acatttgttttggtcctttgga ttctgctggacctagcctaaga 490 bp 55°C 
Exon 13 agcatcttaagtagcagcgat gcaacagcaaaggaaattagaca 298 bp 55°C 
Exon 14 agtggtgctaatattttcccc ctggtcagttgatctttgct 189 bp 58°C 
Secondary structure prediction 
Three different primary structures of albumin, named wild type Albumin, Phe146Leu Albumin, and 
Tyr163His Albumin, were characterized in order to identify differences in secondary structures. 
Each protein sequence was subjected to consensus secondary structure prediction using PSIRED 
(Jones, 1999). 
3.2 Acute phase proteins 
3.2.1 Positive APPs 
Animals and samples 
To investigate the cross reactivity of the antibodies to measure the positive APPs 10 serum samples 
(4 from bottlenose dolphins and 6 from striped dolphins) were used. Bottlenose dolphins’ samples 
were collected from animals under human care in according to Zoo directive DL 73/2005, and DM 
469/2001 and were stored in the Mediterranean Marine Mammals Tissue Bank of the University of 
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Padua, while striped dolphins’ samples were collected from stranded animals during the normal 
veterinary procedures for the health assessment and were stored in the Department of Comparative 
Medical Science of the University of Teramo. All the samples were stored at -20°C until analysis. 
The automatic measurement of positive APPs was performed on 74 serum samples collected from 
bottlenose dolphins under human care. In these animals, in addition to the determination of RIs, 
differences between samples with long (more than 1 year at -80°C) and short (less than 1 year at -
80°C) storage, between male and female animals, and between pregnant and non-pregnant animals 
were evaluated. 
Cross-reactivity evaluation 
To assess the cross-reactivity, seven antibodies against CRP and 2 antibodies against SAA were 
tested with double radial immunodiffusion (DRI) and/or western blot (WB) analysis. The different 
Abs used, the companies, the clones, the target species, and the species in which the Abs were 
validated are reported in table 3.2.1.A. 
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Table 3.2.1.A: antibodies used for double radial immunodiffusion (DRI) and western blot analysis 
(WB). 
Antibody Produced by Clone Produced 
in 
Target 
specie 
Validated 
in 
Methodology 
tested 
CRP Randox, 
Crumlin, UK 
300626 Goat Human Human, dog DRI, WB 
CRP Biodevice, 
Santarcangelo di 
Romagna, 
Rimini, Italy 
CRP005A Non specified Non specified Human DRI 
CRP Aptec, Sint 
Niklaas, 
Belgium 
CRP024 / 
PG4448 
Goat Non specified Human DRI 
CRP Real Time, 
Viterbo, Italy 
1172 Non specified Non specified Human DRI 
CRP Tridelta, 
Maynooth, 
Ireland 
51KT010b Non specified Dog Human, dog DRI 
CRP Ben S.r.l., 
Milano, Italy 
B1424Y Goat Dog Human DRI 
CRP Life 
Diagnostics, 
West Chester, 
PA, USA 
C-G1513A Goat Dog Dog DRI, WB 
SAA Eiken Chemical 
Co., Tokio, 
Japan 
09006 Mouse 
(monoclonal), 
Rabbit 
(polyclonal), 
Goat 
Human Human, 
horse, cat 
DRI, WB 
SAA Tridelta, 
Maynooth, 
Ireland 
24CC017 Multispecies Non specified Multispecies DRI 
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Double radial immunodiffusion 
DRI is an immunological technique used in the identification of antibodies or antigens. In our work, 
0.1% agarose gel were cut to form a series of wells in the gel (Figure 3.2.1.A). Several different 
tests were performed, changing the volume and the dilution of the serum samples and of the Abs 
used. As controls, a healthy human serum sample, serum samples from dogs with high and normal 
CRP concentration, and serum samples from cats with high and normal SAA concentration were 
used. In the central well 20 µl of Ab and in the peripheral wells 12 µl of serum were added or, 
alternatively, 20 µl of serum in the central well and 12 µl of Abs in the peripheral wells. All the 
different tests were summarized in table 3.2.1.B.  
After the Abs and serum samples were putted in the wells, the gels were left for 24 hours in the dark 
in a moist chamber. During this time, the antigens present in the serum and the antibodies each 
diffuse out of their respective wells. Where the two diffusion fronts meet, if any of the antibodies 
recognize any of the antigens, they will bind to the antigens and form an immune complex. The 
immune complex precipitates in the gel to give a thin white line (precipitation line), which is a 
visual signature of antigen recognition. We conducted the experiments testing in parallel 6 different 
serum samples, when the Ab was placed in the central well, or 6 different Abs, when the serum was 
placed in the central well. When more than one well is used, there are many possible outcomes 
based on the reactivity of the antigen and Ab selected. The zone of equivalence line may give full 
identity (when a continuous line is present), partial identity (when a continuous line with a spur at 
one end), or a non-identity (when the two lines cross completely) (Figure 3.2.1.B). 
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Table 3.2.1.B: double radial immunodiffusion tests performed. In the central wells, 20 µl of 
antibody and in the peripheral wells 12 µl of serum were added or, alternatively, 20 µl of serum in 
the central wells and 12 µl of antibodies in the peripheral wells. In each test, each serum 
sample/antibody in the central will react with the antibodies/serum samples present in the six 
peripheral wells. 
Test number Central wells Peripheral wells 
1 CRP Randox undiluted 
CRP Randox diluted 1:2 
SAA Tridelta undiluted 
SAA Tridelta diluted 1:2 
SAA Eiken undiluted 
SAA Eiken diluted 1:2 
Bottlenose dolphin 
Striped dolphin 
Human 
Dog high CRP 
Dog normal CRP 
Cat high SAA 
2 Striped dolphin 
Striped dolphin 
Bottlenose dolphin 
Human 
Dog high CRP 
Dog normal CRP 
Cat high SAA 
Cat normal SAA 
CRP Randox undiluted 
CRP Randox diluted 1:2 
SAA Eiken undiluted 
SAA Eiken diluted 1:2 
SAA Eiken diluted 1:3 
Physiological saline 
3 Striped dolphin 
Striped dolphin 
Bottlenose dolphin 
Human 
Dog high CRP 
Dog normal CRP 
Cat high SAA 
Cat normal SAA 
CRP biodevice undiluted 
CRP Aptec undiluted 
CRP realtime undiluted 
CRP Tridelta undiluted 
CRP Ben undiluted 
SAA Eiken undiluted 
4 CRP biodevice undiluted 
CRP Aptec undiluted 
CRP realtime undiluted 
CRP Tridelta undiluted 
CRP Ben undiluted 
SAA Eiken undiluted 
Bottlenose dolphin 
Dog high CRP 
Striped dolphin 
Dog high CRP 
Human 
Dog high CRP 
5 CRP Life Diagnostic diluted 1:100 
CRP Life Diagnostic diluted 1:1000 
Bottlenose dolphin 
Dog high CRP 
Striped dolphin 
Dog high CRP 
Human 
Dog high CRP 
6 CRP Life Diagnostic diluted 1:5 
CRP Life Diagnostic diluted 1:10 
Bottlenose dolphin 
Dog high CRP 
Striped dolphin 
Dog high CRP 
Human 
Dog high CRP 
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Figure 3.2.1.A: 0.1% agarose gel was cut to form 7 wells. In the central wells 20 µl of antibody and 
in the peripheral wells 12 µl of serum were added or, alternatively, 20 µl of serum in the central 
wells and 12 µl of antibodies in the peripheral wells. Asterisks: precipitation lines. 
 
Figure 3.2.1.B: interpretation of the DRI cross-reaction when the antibody is placed in the central 
well and the serum samples in the peripheral wells. 
 
Western Blot analysis 
The polyacrylamide gel allows separating proteins with a molecular weight (MW) between 4 kDa 
and 200 kDa. The optimal concentration of the polyacrylamide in the gel is based on the MW of the 
proteins of interest. A higher concentration of polyacrylamide is indicated for the low MW proteins; 
on the contrary, a lower concentration of polyacrylamide is better for the high MW proteins. 
* 
* * 
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With this technique, it is possible to separate the proteins based only on their MW. In our work, the 
separation of the serum proteins were performed using 12% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) according to Laemmli protocol (Laemmli, 1970). 
20 µl of working solution (4 µl of serum or Ab plus 11 µl of water plus 5 µl of loading buffer) was 
loaded in the gel and run in a running buffer (TRIS-base 25mM, glycine 192m, 0.1% SDS; pH 8.3) 
at 80V for 30 minutes and then at 100V for 2 hours at room temperature. 
After molecular weight separation, proteins were transferred to a nitrocellulose membrane using a 
trans-blot (Trans Blot turbo, BIO-RAD Transfer system, Hercules, CA, USA). The nitrocellulose 
membrane was then covered with a blocking solution (5% goat milk and 0.05% tween) for 1 hour at 
room temperature. After this, the membrane was washed to complete the blocking of aspecific 
binding site. 
The nitrocellulose membrane was then incubated with the primary antibody (SAA or CRP) (Table 
3.2.1.A) diluted 1:1000 for 1 hour in the dark at room temperature, washed, and then incubated with 
the secondary antibody for 45 minutes in the dark at room temperature. The dilution was 1:4000 for 
the secondary antibody against SAA and 1:3000 for the secondary antibody against CRP. The 
dilution of primary and secondary Abs were performed with 5% goat milk, PBS, and tween. After 
the incubation with the secondary antibody the nitrocellulose membrane was washed. The washing 
procedure consisted in three 5 minutes incubations in PBS buffer 0.1% tween. The membrane was 
then incubated with chemioluminescent AP substrate (Immobilon TM Western, Millipore, Billerica, 
MA, USA) for 5 minutes in the dark at room temperature. The chemoluminescent reaction was 
detected using x-ray (CL-X posure TM film, Thermo Fisher Scientific, Waltham, MA, USA). All 
the different tests were summarized in table 3.2.1.C. 
Table 3.2.1.C: Western blot tests performed. 
Test number Lane Samples Volume of 
samples 
Volume H2O Volume 
loading 
buffer 
1 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Marker 
SAA calibrator 
Empty 
Cat high SAA 
Empty 
Cat normal SAA 
Empty 
Bottlenose dolphin-1 
Striped dolphin-1 
Marker 
 
4 µl (undiluted) 
 
4 µl (undiluted) 
 
4 µl (undiluted) 
 
4 µl (undiluted) 
4 µl (undiluted) 
 
11 µl 
 
11 µl 
 
11 µl 
 
11 µl 
11 µl 
 
5 µl 
 
5 µl 
 
5 µl 
 
5 µl 
5 µl 
2 1 
2 
3 
Marker 
Standard SAA  
Marker 
 
4 µl (undiluted) 
 
 
11 µl 
 
 
5 µl 
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4 
5 
6 
7 
8 
9 
10 
Standard SAA  
Marker 
Standard SAA  
Marker 
Standard SAA  
Standard SAA  
Marker 
4 µl (diluted 1:2) 
 
4 µl (diluted 1:4) 
 
4 µl (diluted 1:8) 
4 µl (diluted 1:16) 
11 µl 
 
11 µl 
 
11 µl 
11 µl 
5 µl 
 
5 µl 
 
5 µl 
5 µl 
3 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Marker 
Cat high SAA 
Cat normal SAA 
Bottlenose dolphin-1 
Striped dolphin-1 
Marker 
Standard SAA  
Standard SAA  
Standard SAA  
Standard SAA  
 
4 µl (undiluted) 
4 µl (undiluted) 
4 µl (undiluted) 
4 µl (undiluted) 
 
4 µl (undiluted) 
4 µl (diluted 1:2) 
4 µl (diluted 1:4) 
4 µl (diluted 1:8) 
 
11 µl 
11 µl 
11 µl 
11 µl 
 
11 µl 
11 µl 
11 µl 
11 µl 
 
5 µl 
5 µl 
5 µl 
5 µl 
 
5 µl 
5 µl 
5 µl 
5 µl 
4 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Marker 
Dog high CRP 
Dog high CRP 
Dog normal CRP 
Bottlenose dolphin-1 
Marker 
Striped dolphin-1 
Standard CRP  
Standard CRP 
Standard CRP 
 
5 µl (undiluted) 
5 µl (diluted 1:2) 
5 µl (undiluted) 
5 µl (undiluted) 
 
5 µl (undiluted) 
10 µ (undiluted)l 
5 µl (undiluted) 
5 µl (undiluted) 
 
10 µl 
10 µl 
10 µl 
10 µl 
 
10 µl 
5 µl 
10 µl 
10 µl 
 
5 µl 
5 µl 
5 µl 
5 µl 
 
5 µl 
5 µl 
5 µl 
5 µl 
5 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Marker 
Dog high CRP 
Dog normal CRP 
Bottlenose dolphin-1 
Striped dolphin-1 
Marker 
Dog high CRP 
Dog normal CRP 
Bottlenose dolphin-1 
Striped dolphin-1 
 
4 µl (diluted 1:20) 
4 µl (diluted 1:20) 
4 µl (diluted 1:20) 
4 µl (diluted 1:20) 
 
4 µl (diluted 1:40) 
4 µl (diluted 1:40) 
4 µl (diluted 1:40) 
4 µl (diluted 1:40) 
 
11 µl 
11 µl 
11 µl 
11 µl 
 
11 µl 
11 µl 
11 µl 
11 µl 
 
5 µl 
5 µl 
5 µl 
5 µl 
 
5 µl 
5 µl 
5 µl 
5 µl 
6 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Marker 
CRP calibrator n°2 
Dog high CRP 
Striped dolphin-1 
Bottlenose dolphin-1 
Bottlenose dolphin-2 
Bottlenose dolphin-3 
Striped dolphin-2 
Striped dolphin-3 
Striped dolphin-4 
 
4 µl (diluted 1:10) 
4 µl (diluted 1:20) 
4 µl (diluted 1:20) 
4 µl (diluted 1:20) 
4 µl (diluted 1:20) 
4 µl (diluted 1:20) 
4 µl (diluted 1:20) 
4 µl (diluted 1:20) 
4 µl (diluted 1:20) 
 
11 µl 
11 µl 
11 µl 
11 µl 
11 µl 
11 µl 
11 µl 
11 µl 
11 µl 
 
5 µl 
5 µl 
5 µl 
5 µl 
5 µl 
5 µl 
5 µl 
5 µl 
5 µl 
7 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Marker 
CRP calibrator n°2 
CRP calibrator n°2 
Empty 
Empty 
Striped dolphin-5 
Empty 
Bottlenose dolphin-4 
Striped dolphin-6 
Empty  
 
4 µl (diluted 1:20) 
4 µl (diluted 1:50) 
 
 
4 µl (diluted 1:100) 
 
4 µl (diluted 1:20) 
4 µl (diluted 1:20) 
 
 
11 µl 
11 µl 
 
 
11 µl 
 
11 µl 
11 µl 
 
 
5 µl 
5 µl 
 
 
5 µl 
 
5 µl 
5 µl 
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Automated measurement of CRP 
The CRP concentration was measured according to the protocol of Klenner and colleagues (Klenner 
et al., 2010) validated in dogs. We used an assay from Randox Laboratories (High Linearity CRP, 
Randox Laboratories Ltd., Crumlin, UK) that consisted of a high-linearity test using an anti-human 
CRP antibody. The assay was run on an automated spectrophotometer (Cobas Mira, Roche 
Diagnostic, Basel, Switzerland) according to the manufacturers’ recommendations and was 
calibrated with test specific calibration material. Briefly, 12 µl of serum were diluted in 150 µl of 
buffer composed by polyethylene glycol, TRIS-HCl, and NaCl. The anti-CRP latex conjugated 
antibody was added to the solution. The antigen-antibody complex precipitates and the 
concentration of CRP was proportional to the increase in absorbance read after 160 seconds at 
340nm of wavelength. 
Automated measurement of SAA 
The SAA concentration was measured according to Christensen and colleagues’ assay, validated in 
dogs, cats, and horses (Christensen et al., 2012). The assay is based on latex-conjugated monoclonal 
anti-human SAA antibody (Eiken Chemical Co., Tokio, Japan) and was measured using the 
automated spectrophotometer ILab300 plus (Instrumentation laboratory, Rome, Italy). Briefly, 3 µl 
of serum were diluted with 3 µl of water and added to the 50 mmol/litre Good’s buffer solution, the 
SAA latex conjugated antibody was added to the solution. The antigen-antibody complex 
precipitates and the concentration of SAA is proportional to the increase in absorbance read after 
296 seconds at 620nm of wavelength. Mann-Whitney test was used to asses if there was differences 
between storage time, sex, and pregnant and non-pregnant animals. 
3.2.2 Negative APP 
PON-1 can be measured based on its activity by spectrophotometric assays. Usually, in veterinary 
medicine, PON-1’s activity is measured using a paraxon-based enzymatic method. However PON-1 
is considered having the ability to hydrolyze many other substrates such as other 
organophosphorous compounds, non phosphorous arylesters (arylesterase activity) and also lactones 
(lactonase activity). For these reasons, PON-1 activity can be measured by different substrates such 
as paroxon, phenyl acetate, 4-nitrophenyl acetate, or dihydrocumarin. 
Animals and samples 
For the measurement performed in University of Milan, Italy, 62 serum samples collected from 
under human care bottlenose dolphins were used. In these animals, in addition to the determination 
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of RIs, differences between samples with long (more than 1 year at -80°C) and short (less than 1 
year at -80°C) storage, between male and female animals, and between pregnant and non-pregnant 
animals were evaluated.  
For the tests performed in Murdoch University, Perth, Western Australia, serum samples from 3 
healthy bottlenose dolphins, 3 diseased bottlenose dolphins, 2 healthy indo-pacific bottlenose 
dolphins (Tursiops aduncus), and 4 diseased indo-pacific bottlenose dolphins were used. These 
serum samples were kindly provided by Dr. David Blyde, and were collected from animals kept 
under human care or hospitalized at Sea World-Gold Coast, Queensland, Australia and stored at – 
20°C until analysis were performed. As controls, serum samples from healthy dogs were used. 
Paraoxonase activity 
The paraoxonase activity was evaluated using paraoxon (Sigma-Aldrich, St. Luis, MO, USA) as 
substrate using automated spectrophotometer (Cobas Mira, Roche Diagnostic, Basel, Switzerland) 
according to the protocol of Feingold and colleagues (Feingold et al., 1998) modified by Rossi and 
colleagues (Rossi et al., 2013). Briefly, 6 µl of serum plus 89 µl of water were added to 100 µl of 
reaction buffer. The reaction buffer is composed by glycine buffer 0.05 mmol, pH 10.5 containing 
1mmol paraoxon-ethyl and 1 mmol CaCl2. The rate of hydrolysis of paraoxon to p-nitrophenol was 
measured by monitoring the increasing in absorbance at 504 nm wavelength using a molar 
extinction coefficient of 18,050 L/mol/cm-1. PON-1 activity expressed as U/mL was defined as 1 
nmol of p-nitrophenol formed per minute under the assay condition. Mann-Whitney test was used to 
asses if there were differences between storage time, sex, and pregnant and non-pregnant animals. 
Since PON-1 is an enzyme associated with high density lipoproteins (HDL), we decided to evaluate 
the concentration of HDL. The HDL concentration was measured following the protocol of Rossi 
and colleagues (Rossi et al., 2014), using an automated spectrophotometer (ILab300, 
Instrumentation Laboratory, Bedford, MA, USA).  
Arylesterase activity 
The evaluation of arylesterase activity was performed at Murdoch University, Perth, Western 
Australia. To evaluate the arylesterase activity two different substrates were used: (1) 4-nitrophenyl 
acetate (4-nPA) (Sigma-Aldrich, St. Luis, MO, USA) using and automated spectrophotometer 
(Cobas Mira, Roche Diagnostic, Basel, Switzerland) and a manual one (UV-1800 Shimadzu 
Spectrophotometer, Shimadzu Corporation, Kyoto, Japan) and (2) phenyl acetate (PA) (Sigma-
Aldrich, St. Luis, MO, USA) using the manual spectrophotometer, according to the protocol 
proposed by Tvarijonaviciute and colleagues (Tvarijonaviciute et al., 2012).  
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Because 4-nPA is insoluble in water, 63 mg of this compound was dissolved in 10 mL of methanol 
and stored at 2° to 8°C. This stock solution can be kept for approximately 1 week. Afterward, 1 mL 
of this solution was slowly added to 20 mL of distilled water with strong agitation to prevent 
precipitation. The aqueous solution was freshly prepared each day.  
Twenty µL of serum samples were mixed with 288 µL of buffer containing 50 mmol Tris-HCl and 
1mmol CaCl2 (pH 8.0) and then 72 µL of freshly made substrate containing 2.5mmol 4-nPA in 
distilled water was added. After 100 seconds, the reaction was monitored at 405 nm at 37°C for 210 
seconds in an automated spectrophotometer. Molar extinction coefficient used to calculate the rate 
of hydrolysis was 14,000 mol–1 cm–1. Because of the lack of a criterion-referenced standard or 
commercially available certified reference material for PON-1 activity, the assay precision was 
evaluated by 10 consecutive repeat measurement of PON-1 activity in 3 serum samples with low, 
medium, and high activity and the assay accuracy was evaluated indirectly through the assessment 
of linearity under dilution (LUD) using a bottlenose serum sample that was serially diluted with the 
working solution without the substrate. 
In the manual spectrophotometer 52.6 µL of serum samples were mixed with 758 µL of buffer 
containing 50 mmol Tris-HCl and 1mmol CaCl2 (pH 8.0) and then 189.5 µL of freshly made 
substrate containing 2.5 mmol 4-nPA in distilled water was added. After 100 seconds, the reaction 
was monitored at 405 nm at 25°C for 225 seconds with the manual spectrophotometer. As a blank, 
the buffer without serum and substrate was used.  
For the evaluation of arylesterase activity using PA, only a manual spectrophotometer with UV 
laser for the detection of the reaction was used. Serum samples were diluted with the buffer 
consisting of 20mmol Tris-HCl and 1mmol CaCl2 (pH 8.0). In a quartz cuvette, a variable amount 
of serum was added to 800 µL of freshly made substrate buffer containing Tris-HCl 20mmol, 
1mmol CaCl2, and 1mmol PA (pH 8.0). The reaction was monitored for 60 or 320 seconds, at 260 
nm at 25°C with a manual spectrophotometer; molar extinction coefficient used to calculate the rate 
of hydrolysis was 1,310 mol–1cm–1. As a blank, the buffer without serum was used. All the test 
conditions were summarized in table 4.2.2.D. 
Lactonase activity  
The evaluation of lactonase activity was performed at Murdoch University, Perth, Western 
Australia, using dihydrocoumarin (DC) (Sigma-Aldrich, St. Luis, MO, USA) as substrate. A 
manual spectrophotometer (UV-1800 Shimadzu Spectrophotometer, Shimadzu Corporation, Kyoto, 
Japan) with UV laser for the detection of the reaction was used. We followed the test conditions 
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reported by Draganov and colleagues (Draganov et al., 2000): in a quartz cuvette containing 800 µL 
of 1 mmol DC in 50 mmol Tris-HCl (pH 8.0) 1 mmol CaCl2, 10 to 40 µL of serum were added. The 
hydrolysis of DC was monitored for 60 or 180 seconds by the increase in UV absorbance at 270 nm 
at 25°C. The molar extinction coefficient used to calculate the activity of PON 1 was 1295 mol–1 
cm–1. As a blank, the buffer without serum was used. All the test conditions were summarized in 
table 4.2.2.E. 
Genetic polymorphisms of PON-1 gene  
For this study, the same DNA samples previously extracted for the determination of the mutations 
responsible of bisalbuminemia were used. 
The structure of the two most studied single nucleotide polimorphisms (SNPs) in the PON-1 gene, 
the Leucine/Methionine in position 55 (L55M) and Glycine/Arginine in position 192 (Q192R) 
(Mackness and Mackness, 2015), was reconstructed by direct comparison of its full length cDNAs 
with the sequence of Tursiops truncatus gene (Gene ID: XM_019927639.1). The coding region of 
the PON-1 gene was screened for alterations by direct sequencing of all samples. The nucleotides’ 
sequence of the PCR primers was taken from literature. They were previously used to detect the 
L55M PON-1 SNP ((Khoshi et al., 2009 ) and the Q192R PON-1 SNP (Browne et al., 2007) in 
human. The primers were tested in DNA extracted from human and dolphins to evaluate if the 
molecular weight and the nucleotide sequence of the PCR amplificate were the same in all the 
species. PCR amplification for L55M SNP was performed in a final volume of 25 µl, containing 50-
100 ng of genomic DNA, 5x AS Reaction Buffer (Fisher Molecular Biology), 500 nmol/L MgCl2, 
400nmol/L each primer, 100 Mmol/L deoxynucleotide triphosphates (Invitrogen), and 0.5 U of Taq 
DNA Polymerase (Fisher Molecular Biology). PCR amplifications for Q192R SNP were performed 
in a final volume of 25 µl, containing 50-100 ng of genomic DNA, 5x Colorless GoTaq® Reaction 
Buffer (Promega), 400 nmol/L each primer, 100Mmol/L deoxinucleotide triphosphates (Invitrogen), 
and 0.5 U of GoTaq® DNA Polymerase (Promega). Cycling conditions (denaturation at 95°C for 
30 seconds, annealing for 30 seconds, and extension at 72 °C for 45 seconds) were repeated for 40 
cycles for both the SNPs. PCR primers and conditions are reported in table 3.2.2.A. Sequencing of 
the PON-1 SNPs was performed using the automatic sequencer 3130ABI PRISM Genetic Analyzer 
(Applied Biosystem). Chromas 1.5 software (Technelysium) and LASERGENE package computer 
programs (DNASTAR) were used to edit, assemble, and translate sequence. 
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Table 3.2.2.A: Oligonucleotide primers used for PCR amplification and DNA sequencing of the 
dolphin’s PON-1 gene. Abbreviation: bp, base pairs. 
SNPs Forward Primer (5’- 
3’) 
Reverse Primer (5’- 3’) Products 
size 
Annealing 
temperature 
L55M cctgcaataatatgaaacaacctg tgaaagacttaaactgccagtc 171 bp 50°C 
Q192R gggacctgagcacttttatggc catcgggtgaaatgttgattcc 176 bp  50°C 
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4. RESULTS 
4.1 Serum Protein Electrophoresis 
4.1.1 Establishment of reference intervals for serum protein fraction in bottlenose 
dolphins 
Reference intervals for serum protein fractions based on AGE are presented in table 4.1.1.A. Intra-
assay and inter-assay repeatability of AGE were reported in table 4.1.1.B. Four main protein 
fractions were evident in all the animals tested: albumin, α-globulins, β-globulins, and γ-globulins 
(Figure 4.1.2.A-a). Moreover, in 8 electropherograms, at a visual inspection, we noticed that the 
base of the albumin peak was wider compared to the electropherograms of the other animals.  
Table 4.1.1.A: reference intervals for total protein and protein fractions (concentration and 
percentage) in bottlenose dolphins. Abbreviations. TP: total protein; SD: standard deviation; LRL: 
lower reference limit; URL: upper reference limit; CI: confidence interval; S: suspected; R: 
removed. 
 Mean Median SD Min Max LRL  
90% CI 
URL 
 90% CI 
Outliers Statistical 
Method 
TP (g/L) 65.5 66.7 5.4 50.8 74.0 54.4 (36.1-
56.5) 
73.5 (72.1-
74.8) 
2S BOX-COX 
transformed 
Albumin  
(g/L) 
45.0 45.0 4.0 36.9 54.1 37.0 (35.0-
39.0) 
53.0 (52.0-
55.0) 
0 Untransformed 
α-
globulins  
(g/L) 
8.0 8.0 1.0 5.3 11.4 5.0 (5.0-6.0) 11.0 (10.0-
12.0) 
1S BOX-COX 
transformed 
β-
globulins  
(g/L) 
5.0 5.0 2.0 2.6 9.3 2.0 (1.0-3.0) 8.0 (7.0-9.0) 0 Untransformed 
γ-
globulins  
(g/L) 
7.0 7.0 2.0 0.0 11.3 2.0 (1.0-4.0) 11.0 (10.0-
12.0) 
1S BOX-COX 
transformed 
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Albumin  
(%) 
69.5 69.6 3.4 61 77.3 62.3 (60.8-
63.7) 
76.4 (74.5-
78.2) 
1S Untransformed 
robust method 
α-
globulins  
(%) 
12.0 12.1 2.1 8.3 16.8 7.6 (6.6-8.5) 16.4 (15.3-
17.4) 
0 Untransformed 
β-
globulins  
(%) 
7.6 6.9 2.1 3.9 13.5 4.2 (3.7-4.7) 12.6 (11.3-
14.4) 
1S BOX-COX 
transformed 
γ-
globulins 
 (%) 
11.2 11.3 2.6 4.2 15.9 6.1 (4.9-7.5) 16.8 (15.4-
18) 
1R, 1S Untransformed 
robust method 
Albumin/
globulins 
ratio 
2.3 2.3 0.4 1.6 3.4 1.7 (1.6-1.8) 3.3 (3.0-3.7) 1S BOX-COX 
transformed 
 
 
 
Table 4.1.1.B: intra-assay (8 runs) and inter-assay (8 runs) imprecision recorded for AGE of 
bottlenose dolphin pooled serum samples reported as coefficient of variations (mean values ± SD) 
for each fraction. 
 Intra-assay Inter-assay 
Albumin 1.2 % (60.9 ± 0.73 g/L) 2.5 % (64.13 ± 1.6 g/L) 
α-globulins 2.9 % (14.1 ±0.4 g/L) 5.7 % (12.0 ± 0.7 g/L) 
β-globulins 3.8 % (9.1 ± 0.4 g/L) 4.0 % (8.6 ± 0.3 g/L) 
γ-globulins 3.4 % (15.9 ± 0.5 g/L) 4.8 % (15.4 ± 0.7 g/L) 
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Figure 4.1.1.A: Graphic representation of the data distribution for total protein, albumin/globulins 
ratio, albumin (g/L and %), α-globulins (g/L and %), β-globulins (g/L and %), and γ-globulins (g/L 
and %). The box represents the interquartile range (IQR) defined by 25th (Q1) and 75th (Q3) 
percentiles with the vertical line representing the median. The horizontal lines are the limits of 
outlies distribution according to Tukey rule. Suspect outliers are indicated in orange and outliers in 
red. 
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Figure 4.1.1.B: Histograms of the data distribution for total protein (g/L), albumin/globulins ratio, 
albumin (%) α-globulins (%), β-globulins (%), and γ-globulins (%). 
 
4.1.2 Identification of bisalbuminemia 
At the visual examination, no double peaks were noted in AGE profiles while 9 out of 40 samples 
(22%) showed a double albumin peak in electrophoretic profile obtained with CZE. However, all 
these samples except 2 had an albumin peak wider than that observed with AGE in dolphins 
classified as non bisalbuminemic by CZE (Figure 4.1.2.A); furthermore a wider albumin peak was 
also noted with AGE in one sample with normal CZE profile. 
The ROC curve analysis showed that when the base/height (b/h) ratio of albumin peak was equal or 
higher than 0.25, the sensitivity and specificity of AGE to detect bisalbuminemic samples were 87% 
and 63% respectively with an area under the curve (AUC) of 0.773. 
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TP levels, albumin percentage and absolute values were not significantly different between normal 
and bisalbuminemic dolphins, but the albumin percentages obtained with CZE were significantly 
lower compared to AGE, either considering the whole data set (P<0.001) and only bisalbuminemic 
samples (P=0.012) (Table 4.1.2.A). 
The bisalbuminemic dolphins belong to two distinct families (Figure 4.1.2.B), they were both male 
and female animals, and this phenotype was evident both in parents and in offspring. In the first 
family, all the siblings derived from the same normal sire were bisalbuminemic, whereas in the 
second family bisalbuminemia was present in a sire and in two out of three siblings. 
 
Table 4.1.2.A: Values of total protein and albumin in bisalbuminemic and normal bottlenose 
dolphins. Values showed represent mean, standard deviation (median and min-max values) of total 
protein (TP) and albumin (percentage and absolute values) obtained using CZE and AGE. *P<0.05 
vs albumin percentage and absolute value measured with AGE. **P<0.001 vs albumin percentage 
and absolute value measured with AGE. 
  CZE tot N=38 AGE tot N=38 
 TP (g/L) Albumin (%) Albumin (g/L) Albumin (%) Albumin (g/L) 
Bisalbuminemic 
(N=9) 
66.5±7.1 
(68.3; 50.8-74.0) 
64.1±3.4* 
(64.1; 58.6-68.1) 
42.4±3.70* 
(43.2; 33.7-46.1) 
70.1±3.6 
(69.9; 64.6-76.0) 
45.5±3.6 
(43.2; 38.6-49.4) 
Normal 64.7±5.8 
(64.9; 48.0-72.7) 
63.3±3.3** 
(62.9; 57.7-72.0) 
40.7±3.4** 
(41.3; 30.9-45.9) 
69.3±3.4 
(69.5; 61.0-77.3) 
45.2±3.9 
(45.0; 36.9-54.1) 
Total 65.0±6.0 
(66.5; 48.0-74.0) 
63.4±3.3** 
(63.5; 57.7-72.0) 
41.0±3.5** 
(41.7; 30.0-45.9) 
69.5±3.4 
(69.5; 61.0-77.3) 
45.2±3.9 
(45.0; 36.9-54.1) 
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Figure 4.1.2.A: Electropherograms of serum samples of unaffected and bisalbuminemic bottlenose 
dolphins. a: Agarose gel electropherogram of serum sample of unaffected bottlenose dolphins, 
showing no abnormality, and b: serum sample from bisalbuminemic bottlenose dolphins, with a 
wider albumin band compared to normal one. c: capillary zone electropherogram of serum sample 
of unaffected bottlenose dolphins and d: from bisalbuminemic bottlenose dolphins, with a double 
albumin peak. 
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Figure 4.1.2.B: Pedigree of two groups of related bottlenose dolphins (family A on the top, family 
B on the bottom). Female are indicated by circles, males by squares. A black circle indicates 
affected dolphins, a white symbol illustrates unaffected dolphins. Red symbols indicate wild 
founders. 
 
4.1.3 Genetic bases of bisalbuminemia 
Mutations in the albumin gene 
Eighteen albumin gene variations were identified in bottlenose dolphins studied; three variations 
were synonymous and 15 were non-synonimous (Table 4.1.3.A). The synonymous variation were 
identified in exons 3, 8, and 9. The non-synonymous variations were identified in exons 4, 5, 6, 7, 
8, 9, 10, 12, and 13. Exons 1, 2, 11, and 14 did not show any variation (Figure 4.1.3.A). In order to 
identify non-synonimous variations able to cause bisalbuminemia, the genotype-phenotype 
correlations within the two families were studied. Two heterozygous non-synonymous variations 
that co-segregate with the ‘’bisalbuminemia’’ phenotype detected by SPE were identified: 
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c.483C>G p.Phe146Leu in exon 4 and c.487T>C p.Tyr163His in exon 5. All bisalbuminemic 
dolphins were heterozygote for both variations and all non-bisalbuminemic dolphins were 
homozygotes (Figure 4.1.3.B). 
 
Table 4.1.3.A: Synonymous and non-synonymous substitutions identified in the 15 related 
bottlenose dolphins and number of heterozygous dolphins for each substitution in the two families. 
In bold the substitutions that co-segregate with phenotype ‘’bisalbuminemia’’. 
 Exons Protein change Family A Family B 
Synonymous substitution Exon 3 p.Ile49Ile 5 3 
 Exon 8 p.Phe332Phe 3 0 
 Exon 9 p.Ala359Ala 3 2 
Non-synonymous substitution Exon 4 p.Asp119Glu 5 2 
 Exon 4 p.Phe146Leu 5 2 
 Exon 5 p.Tyr163His 5 2 
 Exon 5 p.Gly189Ala 6 3 
 Exon 6 p.Thr207Ala 3 2 
 Exon 6 p.Leu208Val 3 2 
 Exon 7 p.His270Tyr 3 2 
 Exon 8 p.His303Asp 4 2 
 Exon 8 p.Leu327Pro 4 2 
 Exon 8 p.Leu328Ile 4 2 
 Exon 9 p.Asp356Glu 4 1 
 Exon 10 p.Arg401Gln 4 1 
 Exon 10 p.Glu419Asp 3 0 
 Exon 12 p.Arg482Gln 5 1 
 Exon 13 p.Ala575Thr 3 0 
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Figure 4.1.3.A: distribution of the mutations identified in albumin gene in 15 bottlenose dolphins. 
The map of the gene were derived from Minchetti and colleagues (Minghetti et al., 1986), modified 
in Minchiotti and colleagues (Minchiotti et al., 2008) and it is adapted for bottlenose dolphins. 
Boxes and lines represent exons and introns, respectively. The open box indicates the completely 
untraslated exon 15. In bold, mutations that co-segregate with phenotype ‘’bisalbuminemia’’, in red 
the synonymous substitutions. 
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Figure 4.1.3.B: Electropherograms showing the mutations identified in exon 4 and exon 5. 
Mutation sites were shown with an asterisk. Panel A: sequences of homozygous allele C in exon 4. 
Panel B: sequence of heterozygous (C/G) alleles in exon 4. Panel C: sequences of homozygous 
allele G in exon 4. Panel D: sequences of homozygous allele T in exon 5. Panel E: sequences of 
heterozygous (T/C) alleles in exon 5. Panel F: sequences of homozygous allele C in exon 5. 
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Secondary structure prediction 
The amino acid change p.Phe146Leu identified in exon 4 is a missense variation that changes a 
nonpolar amino acid, phenylalanine, into another nonpolar amino acid, leucine. The variation 
p.Tyr163His is a missense variation that changes tyrosine, an amino acid with a polar side group, 
into histidine, a positively charged, aromatic amino acid. This amino acid change can cause a 
variation in the secondary and/or tertiary structure of the albumin protein. The in silico analysis of 
these two mutations identified mutation p.tyr163His as the more likely cause of bisalbuminemia in 
these dolphin families. PSIRED was used to predict the secondary structure of wild-type albumin 
and of the two albumin isoforms with the p.Phe146Leu and p.Tyr163His amino acid variations. The 
observed secondary structure of the three proteins show a high degree of similarity in terms of 
helices and β-sheets (Figure 4.1.3.C). The p.Phe146Leu albumin protein showed differences from 
the wild-type albumin in positions 290 to 304, especially in protein binding (Figure 4.1.3.C). 
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Figure 4.1.3.C: PSIPRED prediction of secondary structure maps of dolphin wild-type albumin 
(Panel A) in comparison with dolphin albumin with the variation p.Phe146Leu (Panel B) and 
p.Tyr163His (Panel C). Feature predictions are colour coded into the sequence according to the 
sequence feature key shown below. 
A  
 
B  
 
C  
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Pattern of inheritance and haplotype analysis 
Nine bottlenose dolphins that were analyzed belonged to family A: the founder group was 
composed of three males (Tt1, Tt4, and 1 non examined animal) and two females (Tt2 and Tt3), 
none of which were bisalbuminemic; the first generation was composed of two males (Tt6 and Tt7) 
and two females (Tt5 and Tt8), all of which were bisalbuminemic; and one second generation was 
composed by 1 male (Tt9) which was bisalbuminemic. Six bottlenose dolphins belonged to family 
B: the founder group that was composed of one bisalbuminemic male (Tt10) and three non 
bisalbuminemic females (Tt11, Tt12, and Tt13); and the first generation composed of three males, 
two bisalbuminemic (Tt14 and 1 non examined animal) and one non-bisalbuminemic (Tt15). Based 
on pedigree analysis, and autosomal codominant inheritance pattern was identified (Figure 4.1.2.B). 
The reconstruction of haplotype block for the dolphin albumin chromosomal locus showed three 
different haplotype blocks for this region, named haplotype 1, 2, and 3. All the wild founders, 
except for Tt1 and Tt10, were homozygous for haplotype 1 and they were all caught in the 
surrounding waters of Gulf of Mexico from 1986 to 2003. The wild founder Tt10, caught in the 
Gulf of Mexico in 2003, and dolphins Tt6, Tt8, Tt9, And Tt14, were heterozygous for haplotype 1 
and 2. This indicates the two mutations identified in this study as the responsible for 
bisalbuminemia. In contrast, dolphin Tt1, caught in 1974 in the Adriatic Sea, was heterozygous for 
haplotype 2 and 3. In particular, haplotype 3 is very distinctive because it carries a deletion in exons 
6 and 7 of the albumin gene. Finally, in dolphins Tt5 and Tt7 a crossing over between haplotype 2 
and 3 was evident (Figure 4.1.3.D). 
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Figure 4.1.3.D: pedigree of the two families of Bottlenose dolphins with the observed phenotype. 
Family A and family B. Females are indicated by circles, males by squares. A black symbol 
indicates a bisalbuminemic dolphin, a white symbol illustrates an unaffected dolphin. The 
reconstruction of haplotypes showed presence of three different haplotypes: haplotype 1 is indicated 
by green rectangle; haplotype 2 is indicated by yellow rectangle, and haplotype 3 is indicated by 
blue rectangle. Among dolphins with a homozygous haplotype, 6 are wild founders (Tt2, Tt3, Tt4, 
Tt11, Tt12, and Tt13). In tt5 crossing-over between haplotype 2 and 3 is observed.
. 
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4.2 Acute phase proteins 
4.2.1 Positive APPs 
Cross reactivity evaluation 
Double radial immunodiffusion 
To evaluate the cross-reactivity of the Abs for the determination of the concentration of CRP and 
SAA using DRI technique, 6 different tests were performed. 
In test number 1, the Ab against CRP produced by Randox undiluted and the Ab against CRP 
produced by Randox diluted 1:2 cross-reacted with the serum of dog with high CRP concentration. 
No other precipitation lines were evident. 
In test number 2, the Ab against CRP produced by Randox undiluted and the Ab against CRP 
produced by Randox diluted 1:2 cross-reacted with the serums of dog with high CRP concentration, 
of cat with high SAA concentration, and of cat with normal SAA concentration. No other 
precipitation lines were evident. 
In test number 3, the Ab against CRP produced by Realtime undiluted cross-reacted with the serums 
of healthy human, dog with high CRP concentration, dog with normal CRP concentration, cat with 
high SAA concentration, and cat with normal SAA concentration. The Abs against CRP produced 
by Biodevice and produced by Aptec cross-reacted with serums of dog with high CRP 
concentration, cat with high SAA concentration, and cat with normal SAA concentration. No other 
precipitation lines were evident. 
In test number 4, the Abs against CRP produced by Biodevice, by Aptec, by Tridelta, and by 
Randox cross-reacted with the serum of dog with high CRP concentration. No other precipitation 
lines were evident. 
In test number 5, there were not precipitation lines using the Ab against CRP Life Diagnostics 
diluted 1:100 and diluted 1:1000 and all the serum samples tested. 
In test number 6, the Ab against CRP Life Diagnostics diluted 1:5 and 1:10 cross-reacted with the 
serum of dog with high CRP concentration. No other precipitation lines were evident. 
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Western Blot analysis 
To evaluate the cross-reactivity of the Abs for the determination of the concentration of CRP and 
SAA using WB technique, 7 different tests were performed using 2 Abs against CRP and 1 Ab 
against SAA. 
Using two Abs against CRP tested (Randox and Life Diagnostics), the multimeric forms of CRP 
were evident in dog: a pentamer (150kDa), tetramer ( 100kDa), trimer ( 75 kDa,), dimer ( 45 
kDa). In bottlenose dolphins, a pattern of positivity similar to those observed in dog is present. In 
striped dolphins, a different pattern is evident with only trimer and dimer forms show a positive 
reaction to the Ab. The Ab against SAA tested (Eiken Ltd.) did not show any cross-reaction with 
the serum samples of bottlenose dolphins, but a weak positivity in serum from striped dolphins was 
visible. However, for all the Abs used, unspecific signals were evident. 
Automated measurement of CRP 
The automated measurement of CRP provided discouraging results, indeed in all the animals tested, 
the concentration of CRP was 0.00 mg/L. 
Automated measurement of SAA 
In the entire population of bottlenose dolphins, the RIs for the SAA were (mean ± SD) 8.7 ± 11.8 
mg/L (median: 0.8 mg/L; min-max: 0.0-39 mg/L) (figure 4.2.1.A). No differences were noted 
between different storage time (long storage: mean ± SD 15.7 ± 26.9 mg/L, median 6.8 mg/L, min-
max 0.0-128.7 mg/L; short storage: mean ± SD 13.1±22.3 mg/L, median 0.9 mg/L, min-max 0.0-
87.9 mg/L); between the sex of the animals (female: mean ± SD 14.9 ± 27.3 mg/L, median 1.3 
mg/L, min-max 0.0-128.7 mg/L; male: mean ± SD 13.9±20.9 mg/L, median 5.4 mg/L, min-max 
0.0-84.7 mg/L); and between pregnant and non-pregnant animals (pregnant: mean ± SD 7.2 ± 10.9 
mg/L, median 0.0 mg/L, min-max 0.0-30.0 mg/L; non-pregnant: mean ± SD 20.0 ± 36.1 mg/L, 
median 7.6 mg/L, min-max 0.0-128.7 mg/L) (figure 4.2.1.B). No statistical differences were present 
between the SAA concentration in samples with long storage time and short storage time (P=0.57), 
between the SAA concentration of male and female animals (P=0.76) and between the SAA 
concentration of pregnant and non-pregnant animals (P=0.51). 
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Figure 4.2.1.A: Graphic representation of the data distribution for SAA concentration. The box 
represents the interquartile range (IQR) defined by 25th (Q1) and 75th (Q3) percentiles with the 
vertical line representing the median. The horizontal lines are the limits of outliers distribution 
according to Tukey rule. Suspect outliers are indicated in orange and outliers in red. 
 
 
 
Figure 4.2.1.B: SAA concentration in serum samples with long and short storage time, in serum 
samples from male and female, and in serum samples from pregnant and non-pregnant animals.  
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4.2.2 Negative APP 
Automated measurement of PON-1 
In the entire population of bottlenose dolphins the RIs for the PON-1 activity using paraoxon ad 
substrates were (mean ± SD) 6.7 ± 4.6 U/L (median: 7.3 U/L; min-max: 0.0-14.6 U/L) (figure 
4.2.2.A). As for the concentration of SAA, no statistical differences were present between the PON-
1 activity of female and male animals (female: mean ± SD 6.2 ± 4.5 U/L, median 6.3 U/L, min-max 
0.0-14.6 U/L; male: mean ± SD 7.4 ± 4.6 U/L, median 8.3 U/L, min-max 0.0-13.9 U/L) (P=0.21) 
and between the PON-1 activity of pregnant and non-pregnant animals (pregnant: mean ± SD 4.2 ± 
3.9 U/L, median 5.2 U/L, min-max 0.0-10.4 U/L; non pregnant: mean ± SD 5.5 ± 5.3 U/L, median 
5.3 U/L, min-max 0.0-14.6 U/L) (P=0.76). On contrary the PON-1 activity for the long storage 
samples was significantly lower compared to the short storage samples PON-1 activity (long 
storage: mean ± SD 4.6 ± 4.5 U/L, median 3.8 U/L, min-max 0.0-14.6 U/L; short storage: mean ± 
SD 8.4 ± 3.9 U/L, median 8.9 U/L, min-max 0.0-13.9 U/L) (P=0.001) (figure 4.2.2.B). The mean ± 
SD HDL concentration was 90.4 ± 53.6 mg/dL (median 63.5 mg/dL; min-max 7.3-206.5 mg/dL) 
 
 
Table 4.2.2.A: reference intervals for SAA concentration and paraoxonase PON-1 activity in 
bottlenose dolphins. Abbreviations. SD: standard deviation; LRL: lower reference limit; URL: 
upper reference limit; CI: confidence interval; Out: outliers; S: suspected; R: removed. 
 Mean Median SD Min Max LRL  
90% CI 
URL 
 90% CI 
Outliners Statisitcal 
Methods 
SAA 
(mg/L) 
8.7 0.8 11.8 0 39 0.0 (0.0-0.0) 37.7 (33.1-
39.0) 
4R, 1S Non parametric 
PON-1 
(U/L) 
6.7 7.3 4.6 0 14.6 0.0 (0.0-0.0) 14.5 (13.5-
14.6) 
0 Non parametric 
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Figure 4.2.2.A: Graphic representation of the data distribution for PON-1 activity using paraoxon 
as substrate. The box represents the interquartile range (IQR) defined by 25th (Q1) and 75th (Q3) 
percentiles with the vertical line representing the median. The horizontal lines are the limits of 
outliers distribution according to Tukey rule. Suspect outliers are indicated in orange and outliers in 
red. 
 
 
 
Figure 4.2.2.B: PON 1 activity using paroxone as substrate in serum samples with long and short 
storage time, in serum samples from male and female, and in serum samples from pregnant and 
non-pregnant animals.  
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The automatic measurement of PON-1 activity using 4-nPA as substrate provides results with good 
precision but low accuracy. The results for intra-assay precision was reported in table 4.2.2.B. The 
accuracy of the assay was determined by LUD. The least square linear regression on mean values of 
LUD demonstrated a good correlation with r2 = 0.87, however the correlation was affected by three 
serum samples with different dilution that provide quite the same results. (Graphic 4.2.2.A). Based 
on Mann-Whitney test, no significant difference were noted between healthy dolphins (mean ± SD: 
186.2 ± 20.4 U/L, median: 187.2 U/L; min-max: 154.9-209.6 U/L) and diseased dolphins (mean ± 
SD: 177.5 ± 14.3 U/L, median: 177.5 U/L; min-max: 156.2-194.2 U/L) (P=0.57).  
 
Table 4.2.2.B: intra-assay precision of the paraoxonase-1 (PON-1) enzymatic activity using 4-nPA 
as substrate determined with 10 consecutive repeat measurements on bottlenose dolphin’s serum 
samples with low, medium, and high PON-1 activity. 
 Low Medium High 
Min-Max (U/L) 130.6-135.0 134.4-137.2 152.3-155.1 
Mean value (U/L) 132.4 135.9 154.1 
SD (U/L) 1.3 0.8 0.8 
CV (%) 1.0 0.6 0.5 
 
Graphic 4.2.2.A: Linearity under dilution (LUD) of PON-1 activity using 4-nPA as substrate in 
serially diluted serum sample with basal PON-1 activity of 193.4 U/L. Each data point indicates the 
mean of a triplicate measurement. The line indicates the linear correlation between expected and 
observed values. 
 
R² = 0,8715
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Manual measurement of PON-1 
The arylesterase activity using 4-nPA as substrate was also determined with a manual 
spectrophotometer. The test conditions and the PON-1 activity obtained were reported in table 
4.2.2.C.  
Moreover, the arylesterase activity of PON-1 using PA as substrate and the lactonase activity of 
PON-1 using DC as substrate were evaluated with the manual spectrophotometer, since the 
automated spectrophotometer was not equipped with the UV light, and the correct wavelength to 
evaluate the hydrolysis of PA is 260 nm and the hydrolysis of DC is 270 nm. The PON-1 activity 
measured using PA provides results with high variability, in 6 tests no reactions were evident, and 4 
tests provided negative activity while using DC no reactions were evident. The test conditions and 
the PON-1 activity were reported in table 4.2.2.D (PA) and 4.2.2.E (DC). 
 
Table 4.2.2.C: test conditions and results of the evaluation of the PON-1 arylesterase activity using 
4-nitrophenyl acetate as substrate. Offshore means animals that live in deep water, far from the 
coastline. 
Animal Serum’s 
dilution 
Serum amount 
(µl) 
Reading time (sec) Activity (U/L) 
Offshore healthy 1:5 52.6 225 87.44 
Offshore healthy 1:10 52.6 225 64.35 
Offshore healthy 1:20 52.6 225 47.79 
Offshore healthy 1:5 52.6 225 37.62 
Offshore healthy 1:10 52.6 225 18.81 
Offshore healthy 1:20 52.6 225 9.41 
Offshore healthy 1:10 52.6 225 23.81 
Offshore healthy 1:12 52.6 225 21.02 
Offshore healthy 1:14 52.6 225 21.22 
Offshore healthy 1:16 52.6 225 16.45 
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Offshore healthy 1:18 52.6 225 13.76 
Offshore healthy 1:20 52.6 225 14.44 
Offshore healthy undiluted 52.6 225 184.65 
Offshore healthy 1:5 52.6 225 87.18 
Offshore healthy 1:10 52.6 225 64.09 
Offshore healthy 1:20 52.6 225 47.52 
 
Table 4.2.2.D: test conditions and results of the evaluation of the PON-1 arylesterase activity using 
phenyl acetate as substrate. Offshore means animals that live in deep water, far from the coastline. 
Animal Serum’s 
dilution 
Serum amount 
(µl) 
Reading time (sec) Activity (U/L) 
Offshore healthy 1:3 20 60 No reaction 
Offshore healthy 1:3 40 60 No reaction 
Offshore healthy 1:3 60 60 2442.14 
Offshore healthy 1:3 80 60 No reaction 
Offshore healthy Undiluted 10 60 No reaction 
Offshore healthy Undiluted 20 60 No reaction 
Offshore healthy Undiluted 30 60 No reaction 
Offshore healthy 1:1.5 60 60 1659.27 
Offshore healthy 1:1.5 60 60 3888.05 
Offshore healthy 1:1.5 60 60 288.85 
Offshore healthy 1:3 60 320 1165.27 
Offshore healthy 1:3 60 320 1240.76 
Offshore healthy 1:3 60 320 774.66 
Offshore healthy 1:3 60 320 623.66 
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Offshore healthy 1:1.5 60 320 53.26 
Offshore healthy 1:40 20 60 -7870.23 
Offshore healthy 1:40 40 60 -641.22 
Offshore healthy 1:40 40 60 -1410.69 
Offshore healthy 1:40 40 60 -1282.44 
 
Table 4.2.2.E: test conditions and results of the evaluation of PON-1 lactonase activity using 
dihydrocoumarin as substrate. Offshore means animals that live in deep water, far from the 
coastline. 
Animal Dilution Serum amount 
(µl) 
Reading time (sec) Activity (U/L) 
Offshore healthy Undiluted 10 60 No reaction 
Offshore healthy Undiluted 20 60 No reaction 
Offshore healthy Undiluted 40 60 No reaction 
Offshore healthy Undiluted 20 180 No reaction 
Genetic polymorphisms of PON-1 gene  
Since the primers used to detect SNPs L55M and Q192R were designed to amplify human DNA, 
we tested the primers on human and dolphin DNA to verify the cross-reactivity of the primers. The 
figure 4.2.2.C showed the obtained results that indicated the length of the amplicon is the same for 
dolphins and human. In order to verify also that the DNA sequence is correct we sequenced the 
obtained PCR products of humans and dolphins confirming that the PCR specifically amplified 
respectively humans and dolphin PON-1 gene.  
Based on the sequence analysis, all the dolphins were homozygous for Metionin in L55M SNPs and 
for Arginin in Q192R SNPs. 
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Figure 4.2.2.C: PCR products of SNPs L55M (A) and Q192R (B). The bands of the human’s 
L55M and Q192R had the same length of the dolphin’s L55M and Q192R. DNA Marker-100bp 
(DNA Ladder, Invitrogen) Abbreviation. H: human; D: dolphin; -: negative control.  
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5. DISCUSSION 
5.1 Serum Protein Electrophoresis 
5.1.1 Establishment of reference intervals for serum protein fraction in bottlenose 
dolphins 
Serum protein electrophoresis is the most reliable method to determine the distribution of serum 
protein fractions and it is considered, together with a basic haematological and biochemical profile, 
an essential step to evaluate the health status of animals, providing clinical useful information. The 
interpretation of kinetics of total proteins and albumin and globulin fractions is receiving increased 
attention also in marine mammals in which, as in terrestrial mammals, a typical pathologic pattern 
could be identified in several diseases, such as inflammatory diseases (King et al., 2001). The 
measurement of serum protein’s fractions can be performed with different techniques, such as 
cellulose acetate electrophoresis (CAE), AGE, and CZE. Nowadays, in human medicine, CZE has 
replaced classical AGE, due to its higher resolution. However, the higher cost of CZE, compared to 
the most traditional techniques, hampered its wide diffusion also in veterinary laboratories. So, we 
decided to determine the RIs of serum protein’s fractions in bottlenose dolphins kept under human 
care using AGE because it is the more common methods to measure the serum proteins’ fraction in 
companion animals (Giordano and Paltrinieri, 2010) and also in dolphins (Schwacke et al., 2009). 
Compared to previously published data in free ranging bottlenose dolphins (Schwacke et al., 2009), 
in our samples the concentration of TP, α-globulins, and γ-globulins were slightly lower; while the 
concentration of albumin and the albumin/globulins ratio were slightly higher. Haptoglobin and the 
anti-inflammatory proteins α1-antitrypsin, α1-antichymotripsin, and α2-macroglobulin migrate in 
the α-globulins fraction, while the IgG and CRP migrate in the γ-globulins fraction(Stockham and 
Scott, 2008b). Albumin acts as a negative acute phase protein since the synthesis of this protein is 
decreased during an inflammation(Stockham and Scott, 2008b). The lower concentration of 
‘’inflammatory’’ proteins associated to a higher concentration of albumin and the consequent higher 
albumin/globulins ratio reported in our study could reflect a lower antigenic stimuli in the animals 
housed in aquaria compared to the free-ranging populations. Moreover, in the paper of Schwacke 
and colleagues (Schwacke et al., 2009) the possible non-healthy individuals were not excluded from 
the studied population, so it is possible that the RIs proposed did not represent a strictly disease-free 
population. On contrary, the serum samples used in our work were collected from animals with 
normal clinical history and physical examination  
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The RIs for serum proteins’ fraction reported in the present study extend the toolbox of diagnostic 
and monitoring tools available for dolphins. The current study is limited by the relatively small 
sample size. In the future, when larger sample sets will be available, the development of RIs for 
under human care bottlenose dolphins associated with age and sex may be possible. The intra-assay 
imprecision for AGE of bottlenose dolphins serum samples was between 1.2% and 3.8% and inter-
assay imprecision was between 2.5% and 5.7% for the different protein fractions (table 4.1.1.B). 
This data are similar to the intra- and inter-assay imprecision recorded for AGE of canine and feline 
serum samples (Giordano and Paltrinieri, 2010). It is possible that the variability recorded in this 
study had influenced the RIs of the poorly represented serum protein fractions, but this happens also 
for the other species, for which SPE is widely used.  
Moreover, at a visual examination of the AGE electropherograms, in 7 animals wider albumin 
peaks were evident. For this reason, we decided to investigate all the serum samples with CZE 
because it allows a better visualization of the albumin fraction. However, we were not able to 
perform the inter-assay and intra-assay repeatability and coefficient of variation on CZE, so despite 
the presence of data regarding the absolute values and the percentage of the different serum protein 
fractions, we cannot determine the RIs of bottlenose dolphins’ serum proteins obtained with this 
technique.  
5.1.2 Identification of bisalbuminemia 
The analysis of CZE profile revealed the presence of a double albumin peak in 9 bottlenose 
dolphins from two distinct families, thus we report for the first time the presence of hereditary 
bisalbuminemia in two groups of related bottlenose dolphins identified by means of CZE and we 
confirm that AGE could fail in the identification of this alteration, as already reported in human 
medicine (Jaeggi-Groisman et al., 2000, Kalambokis et al., 2002). In human medicine, CZE has 
replaced classical AGE, due to its higher resolution. The difference in resolution is mainly due to 
the different analytic method: while in AGE, proteins migrate toward anode in a solid phase and in 
an alkaline buffer with low voltage, in CZE proteins rapidly move in a liquid phase toward the 
cathode thanks to the high voltage applied. This allow a better separation of proteins with similar 
physiochemical characteristics, thus generating multiple sub-peaks or narrower peaks (Bossuyt et 
al., 2003). When CZE was introduced routinely in human medicine laboratories, an increased 
number of bisalbuminemia cases was detected (Jaeggi-Grosiman et al., 2000), based on the 
improved separation of the albumin, α1-globulin, and α2-globulin fractions. In our work, this 
technique clearly identified a double albumin peak at the visual analysis of the electrophoretic 
profile in 9 samples whereas with AGE only 8 profiles revealed a wider peak compared to the 
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normal one, but never an albumin double peak was detected. Furthermore, with AGE, an albumin 
peak apparently wider than normal was noted also in one sample with normal CZE profile, 
demonstrating as the visual interpretation of AGE profiles could lead to both false negative and 
false positive detection of bisalbuminemia. However, the visual identification of a ‘’wider’’ peak 
could be considered a subjective method. Thus, we calculate the ratio between the length of the base 
and the height of the albumin peak with the aims to define a cut-off and to establish a more accurate 
and objective method to identify bisalbuminemia in AGE electrophoretic profile. However, also 
with this approach the diagnostic accuracy was fair with a low specificity. 
As expected, no significant differences in TP concentration, albumin percentage and absolute values 
between affected and normal dolphins was noted, but CZE albumin were significantly lower 
compared to AGE. In literature, an opposite situation is reported with higher albumin values 
obtained with CZE in dogs and cats (Giordano and Paltrinieri, 2010). Nevertheless, it is possible 
that these data, despite the significant differences, are not clinically relevant. In literature, RIs for 
TP and serum protein fractions are available for free ranging bottlenose dolphins (Goldstein et al., 
2006; Schwacke et al., 2009b): compared to our results obtained with both methods, in free-ranging 
dolphins TP seemed higher and albumin absolute values lower, suggesting a higher concentration of 
globulins in these animals, thus a tendency to an inflammatory status, as already suggested (King et 
al., 2001). All these data highlight the need to define appropriate RIs for different electrophoretic 
methods for bottlenose dolphins under human care. 
The application of higher resolution techniques, such as CZE, can result in an increased number of 
‘’abnormal’’ profiles and thus a deeper knowledge of the clinical importance of these new profiles 
is required. In previous works in CZE validation in companion animals, an unusual albumin peak 
was observed in sera from clinically healthy cats never been reported previously, likely because of 
the low resolution of traditional electrophoretic techniques (Giordano and Paltrinieri, 2010). Thus, 
the correct interpretation of these kinds of data is essential to differentiate normal to pathological 
conditions. In human medicine, the diagnostic implications of the presence of bisalbuminemia in 
clinical entities are uncertain: it could be a sign of acquired disorders and it is correlated with 
several pathological conditions, like pancreatic and hepatic diseases (pancreatitis, pancreatic 
pseudocyst, hepatic cirrhosis) or lymphoproliferative diseases (monoclonal gammopathy, multiple 
myeloma) (Ejaz et al., 2004). In our case, all the sampled dolphins were clinically healthy, without 
any other alteration in haematological or biochemical parameters and bisalbuminemia was detected 
accidentally, during the routine evaluation of the health status. Furthermore, no drugs were 
administered to the affected animals, except for an integration of folic acid in two of them, thus we 
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could exclude the possibility that the abnormal electrophoretic pattern identified is due to a 
pathological condition or drugs administration. 
The inherited form of human bisalbuminemia is usually discovered by chance and apparently does 
not seem associated with pathological conditions. Genetically, bisalbuminemia is due to a mutation 
in the albumin gene transmitted as an autosomal codominant trait and it has been reported in various 
human populations around the world, with significant differences in frequency in terms of race and 
location, with a higher incidence in small, isolated population groups (Minchiotti et al., 2008). All 
the dolphins sampled in our study were living under human care and, from a reproductive point of 
view, they include wild founders and their progeny of first and second generation maintained in 
four groups separated in different facilities; for this reason the high incidence of this inherited 
disorder is somehow concentrated and not surprising. 
Since the protein synthesis is governed by a single copy gene codominantly expressed, 
heterozygous subjects carrying point mutations usually show the presence of the normal and the 
variant proteins. Based on the pedigree of affected dolphins, we could only suppose the same 
inheritance pattern in bottlenose dolphins. Over the last three decades, more than 60 different 
albumin variants have been characterized in people, being the vast majority reflecting single-base 
changes in the structural gene mainly with mutations in hypemutable CpG dinucleotides (Kragh-
Hansen et al., 2013). Rarely, the presence of bisalbuminemia may have clinical impact due to the 
effect of mutation on ligand-binding: three mutations (p.Leu90Pro, p.Arg242His, and p.arg242Pro) 
form strong bindings sites for triiodothyronine (T3) or thyroxine (T4), causing the familiar 
dysalbuminemic hyperthyroxinemia syndrome (Galliano et al., 1990; Petersen et al., 1994). Other 
mutations seem to increase the binding capacity of long-chain fatty acids, but without clinical 
consequences (Nielsen et al., 1997). However, in sampled dolphins, apparently, no signs of altered 
hormone or lipid binding capacity were evident based on the absence of laboratory abnormalities. 
To investigate the possible mutations responsible of bisalbuminemia, the inheritance pattern of this 
disorder and the possible alteration in the albumin functions, the genetic analysis of the albumin 
gene of 15 dolphins belonging to 2 families were carried out. 
5.1.3 Genetic bases of bisalbuminemia 
The genetic analysis of bottlenose dolphins’ albumin gene showed a significant polymorphism and 
two mutations associated with bisalbuminemia. Moreover, we were able to identify the autosomal 
codominant trait of this condition in dolphins, a similar pattern of inheritance to that in humans. By 
analysing samples from two dolphin families in which a recurrence of bisalbuminemia had been 
detected by serum protein electrophoresis, 18 variations in the coding sequence, three of which are 
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synonymous and 15 are non-synonimous, were identified. Non-synonimous variations are 
nucleotide changes that alter the amino acid sequence of a protein, thus, these substitutions could be 
the cause of bisalbuminemia in dolphins as in humans (Kragh-Hansen et al., 2013). The mutation 
p.Phe146Leu in exon 4 changes phenylalanine, a neutral, nonpolar, amino acid, into leucine, 
another nonpolar amino acid containing an α-amino group, an α-carboxylic acid group, and an 
isobutyl side chain. Based on the secondary structure study, this mutation could induce a disordered 
protein binding. Usually, bisalbuminemia is detected with standard electrophoretic methods under 
non-denaturing conditions when the mutation induces a change in charge placed on the surface of 
the protein, while mutations affecting binding properties are less likely causes of bisalbuminemia 
(Kragh-Hansen et al., 2013). Therefore, we could presume that this mutation is less likely to be the 
cause of bisalbuminemia, even if we cannot exclude the possible effect on the binding capacity of 
this albumin variant. In contrast, the variation p.Tyr163His in exon 5 is a missense variation that 
changes tyrosine, an amino acid with a polar side group classifying it as hydrophobic, into histidine, 
which contains an α-amino, a carboxylic acid group, and a side chain imidazole, classifying it as a 
positively charged, aromatic amino acid. The in silico analysis and the comparison between dolphin 
and human variations showed that this variation has a homolog variation in human albumin, 
p.Tyr164Cys, verified to be able to cause bisalbuminemia and named ‘’Asola’’ by Minchiotti and 
co-authors (Minchiotti et al., 1995). These data support the hypothesis that the variation 
p.Tyr163His could be more likely responsible for bisalbuminemia. 
The identification of the same mutation in humans and dolphins could be due to recurring 
bisalbuminemias being linked to hypermutable CpG regions present in both species (Kragh-Hansen 
et al., 2013). This hypothesis is supported by the detection of the same mutation in bisalbuminemic 
dolphins from two unrelated families. In humans, the identification of the same albumin variant in a 
distant ethnic group has also been reported (Galliano et al., 1999) and, as it is unlikely that an 
evolutionary advantage derived from the mutation, our findings confirmed the presence of 
conserved hypermutable sites in albumin genes. 
This evaluation of the causative defect of bisalbuminemia is of interest because, in some 
circumstances, the mutations could affect the ligand-binding activity. Usually this effect is small, 
but some human variants increase the albumin binding capacity for triiodothyronine and thyroxine, 
leading to a clinically relevant euthyroid hyperthyroxinemia (Petersen et al., 1994). Other mutations 
affect the albumin affinity for endogenous and exogenous ligands such as long-chain fatty acid, 
copper, nickel, and some drugs (e.g. diazepam, warfarin), but no clinical consequences have been 
reported (Minchiotti et al., 2008). In humans, the ‘’Asola’’ albumin, homologous to the variant 
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reported here, is not reported to cause these types of alterations, and the dolphins enrolled in our 
study were clinically healthy. Thus, we can suppose that the mutation p.Tyr163His recognized in 
this work does not modify albumin function. 
The haplotype analysis revealed that in the two families there are three different haplotypes. The 
majority of wild founders had the same homozygous haplotype (haplotype 1) and they were all 
caught from 1986 to 2003 in the surrounding waters of Gulf of Mexico. The only wild founder 
caught in the Gulf of Mexico that showed a heterozygous haplotype was Tt10, a subject with a very 
heterogeneous composition of alleles both homozygosity and heterozygosity with a differential 
pattern: he was heterozygous for two different haplotype, each of which carries the two mutations 
identified in this work. This is consistent with the fact that Tt10 was the progenitor carrying the 
causative mutation of bisalbuminemia in family B. In contrast, Tt1 had a heterogeneous haplotype 
consistent with the fact that it was caught in 1974 in the Adriatic Sea, a different area than where 
the other wild founder dolphins analyzed in this study were from. This dolphin had two different 
haplotypes, each of which carries the two mutations identified in this work: it was homozygous for 
both mutations, not bisalbuminemia, but all his siblings were bisalbuminemic. These data suggest 
that dolphins Tt1 and Tt10 were the ancestors who introduced the mutation responsible for 
bisalbuminemia into family A and family B, respectively. Dolphin Tt10 was bisalbuminemic, and 
was heterozygous at the two mutations: 66% of his descendants were bisalbuminemic. Dolphin Tt1 
was not bisalbuminemic, because it was homozygous for the two mutations and all his denscendants 
are bisalbuminemic. It remains unclear if haplotype 2, which carries the mutation responsible for 
bisalbuminemia in both families analyzed in this paper, identified in the dolphin Tt1 and Tt10, was 
inherited from a common ancestor or is the consequence of different mutation, and the resulting 
same haplotype is the effect of natural selection. The fact that dolphins Tt1 and Tt10 were wild 
founders caught in distant areas, the Adriatic Sea and the Gulf of Mexico respectively, suggested 
that they did not have a common ancestor. We could therefore speculate that mutations leading to 
bisalbuminemia in these two dolphins are located in hypervariable regions of the genome of the 
dolphins, as also happens in humans. 
 
5.2 Acute Phase Proteins 
The measurement of APPs in association to serum proteins’ fractions can supplement and extend 
the baseline informations obtained from the complete blood cell count, fibrinogen, and standard 
serum chemistry panel (Isaza et al., 2014). In our study, two positive APPs, CRP and SAA, and one 
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negative APP, PON-1, were investigated. The concentration of the positive APPs were determined 
by immunoturbidimetric methods, while the activity of the negative APP was based on enzymatic 
activity.  
5.2.1 Positive APPs 
Cross-reactivity evaluation 
Double radial immunodiffusion 
To identify at least one Ab to measure the concentration of CRP in the serum samples of bottlenose 
dolphins and striped dolphins, several Abs were tested. None of the Abs tested cross-reacted with 
the serum samples of bottlenose dolphins or striped dolphins. Moreover, when the Abs were placed 
in the central wells and the serum samples in the peripheral wells, the precipitation lines were 
evident only between the Abs and the serum of dog with high concentration of CRP, except for the 
test number 5, in which the Ab were diluted 1:100 and 1:1000, and no precipitation lines were 
evident. Conversely, when the serum samples were placed in the central wells and the Abs in the 
peripheral wells, more serum samples cross-reacted with the Abs. For example in test number 1 and 
2 the same serum samples and the same Abs were used (table 3.2.1.B). In the test number 1, the Abs 
were placed in the central wells and the serum samples in the peripheral wells, in the test number 2 
the serum samples were placed in the central wells and Abs in the peripheral wells. In test number 
1, the precipitation lines were evident between the Abs produced by Randox and the serum samples 
of dog with high concentration of CRP. In test number 2, the precipitation lines were evident 
between the Abs produced by Randox and the serum samples of dog with high concentration of 
CRP, cat with normal concentration of SAA, and cat with high concentration of SAA. The capacity 
of the central wells was 20 µl, while the capacity of the peripheral wells was 12 µl. The higher 
number of serum samples that cross-reacted with the Abs when the serum samples were placed in 
the central wells could indicate a low analytic sensitivity of the DRI, which needs a high amount of 
antigens to provide significant precipitation lines. The lack of precipitation lines when the Ab 
against CRP produced by Randox was highly diluted (1:100 and 1:1000) confirms the low analytic 
sensitivity. 
No precipitation lines were evident when the Abs against SAA were tested, whether the Abs or the 
serum samples were placed in the central well. Both the Abs tested were latex-conjugated, because 
produced for automatic immunoturbidimetric assays. The presence of latex associated to the Abs 
may have interfered to the migration of the Abs across the agarose gel. 
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Western blot analysis 
The WB analysis is a high specific technique that allows separating the proteins based only by their 
size thanks to the treatment with SDS that linearize and make negative the proteins (Sanders et al., 
2016). Once separated, the protein bands are transferred to a porous membrane by electroblotting. 
The porous membrane enables access to antibodies to the protein bands for immunodetection 
(Burnette, 1981). Thus, this test is considered one of the most reliable for the evaluation of 
antibodies cross-reactivity. In our work, we confirmed the cross-reaction of the Abs against CRP 
tested with the serum samples of human, dogs and cats, while the pattern of positivity in the serum 
samples of bottlenose dolphins and striped dolphins was difficult to interpret: in bottlenose dolphins 
the pattern was similar to those observed in dog, with different multimeric CRP forms and in striped 
dolphins only dimer and trimer forms were positive. However, we are not able to exclude the 
possibility that the multiple bands are not only related to different CRP forms, but they may 
represent an unspecific signal. The anti-CRP Abs used for both DRI and WB were specific for 
human CRP or canine CRP and no Abs against dolphins’ CRP are commercially available. It is 
possible that the anti-CRP Abs do not recognize the cetaceans CRP, based also on the low 
homology of the amino acid sequence between the bottlenose dolphins CRP and the human and 
canine CRP (64%). The discouraging results obtained with the automated measurement of dolphins 
CRP seemed to confirm this conclusion.   
The anti-human Ab against SAA tested cross-reacted with the serum samples of striped dolphins 
but not with the serum samples of bottlenose dolphins. The SAA is highly conserved between 
different species (Uhlar and Whitehead, 1999) and the homology of the amino acid sequence 
between the bottlenose dolphins’ SAA and the human’s SAA is 75.4%, no data regarding the 
homology of the amino acid sequence between the striped dolphins’ SAA and the human’s SAA is 
present. However, a previous work (Segawa et al., 2013) reported as, in bottlenose dolphins only 
one circulating highly alkaline SAA isoform is present (SAA-3), unlike other terrestrial mammal, 
except for pig, and they supposed that SAA in dolphins may have different functions compared to 
other mammals based on their different evolutionary processes. Thus, we cannot exclude that our 
different WB result in bottlenose and striped dolphins could be related to some differences in 
isoform distribution between these two species.  
To further analyse the possible cross-reaction of commercial anti-CRP and anti-SAA Abs, we 
decided to measure the concentration of CRP and SAA using an immunoturbidimetric assay. We 
used 74 serum samples of healthy bottlenose dolphins to obtain the RIs, to assess if the storage time 
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affects the concentration of these positive APPs and to evaluate if exists differences between male 
and female and between pregnant and non-pregnant animals.  
Automated measurement of CRP  
The concentration of CRP in bottlenose dolphins determined by the automated spectrophotometer 
Cobas Mira was 0.00 mg/dL. The result it is not surprising and confirm the lack of cross-reaction 
proved with DRI and WB. In a previous work (Cray et al., 2013), the authors provided the RIs of 
CRP for bottlenose dolphins, using a different antibody which was also tested in our work, but only 
in DRI and WB. It is possible that the two Abs are directed against different epitopes of CRP with 
different level of homology and conservation between species. This data underlines the importance 
of the complete validation process when immunological assay were validated in new species. 
Based on the results of the cross-reactivity evaluation and of the automated measurement, we can 
conclude that the CRP cannot be used as health marker in bottlenose dolphin and striped dolphin. 
Automated measurement of SAA 
The RIs for SAA obtained in our work are quite lower compared to the previously published RIs for 
bottlenose dolphins (Cray et al., 2013), manatee (Trichecus manatus) (Harr et al., 2006), and 
terrestrial mammals (Christensen et al., 2012). These data reflect the importance that each 
laboratory create its own specific RIs. 
No differences were evident between long or short storage time, males or females, and pregnant 
animals or non-pregnant animals. Partitioning into subclasses should be based on physiologic 
differences that are expected to results in important clinical differences in RI. Partitioning favours 
homogenous subpopulations, decreasing variability between individuals and narrowing the RIs. 
However, partitioning should be considered only if there are at least 40 individuals within each 
subclass (Friedrichs et al., 2012). The management of under human care dolphins is regulated by 
strictly laws, moreover few dolphinaria meet the condition to house dolphins in the Mediterranean 
Sea. For these reasons, it is difficult to obtain a large number of bottlenose dolphins serum samples. 
The lack of differences in SAA concentration between males and females, and between pregnant 
and non-pregnant animals allows establishing the SAA RIs using a larger number of samples 
instead of establish the SAA RIs partitioned for sex or pregnant status, decreasing the number of 
samples in each subgroups. Further studies will be focused to investigate if the age of animals could 
affect the SAA concentration or not, as it happens in human, where no age-related changes were 
noted (Hijmans and Sipe, 1979). The stability of SAA over time was previously evaluate in human 
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(Rothkrantz-Kos et al., 2003), horses (Hillström et al., 2010; Pepys et al., 1989) and cows (Tóthová 
et al., 2012), with different results. In humans and horses no differences over time were evident for 
frozen samples or samples stored at +4°C and at room temperature, on contrary in cows a decrease 
in SAA concentration was evident from storage-day 2 in frozen samples. In our work no difference 
in SAA concentration in long storage time samples compared to the short storage time samples was 
evident, this allows to put together samples collected in different time, to increase the cohort of 
samples used to generate the RIs. 
Unfortunately, the tested animals were all healthy, so we could not evaluate the change in 
concentration in diseased animals. The only test in a non-healthy animal was performed in a striped 
dolphins stranded because of a wound in the caudal peduncle. For this animal 3 serum samples 
collected in 3 consecutive days were available. Interestingly the concentration of SAA increased 
from the first to the last sample and the increase was proportionally to the deterioration of the 
clinical condition of the animal, reaching the maximum concentration of 128.0 mg/dL the day of the 
death (Bonsembiante et al., 2017). The maximum concentration reached in the diseased animal was 
lower compared to the SAA concentration in diseased manatees (Harr et al., 2006). Thus, we could 
speculate that the dolphins have lower concentration of SAA than manatees, and that also the 
magnitude of concentration’s increase in diseased animals is lower. 
5.2.2 Negative APP 
The activity on PON-1 has never been evaluated in marine mammals before, so our results were 
compared to the RIs of dogs (Rossi et al., 2013) and pigs (Escribano et al., 2015). We used two 
different substrates (paraoxon and 4-nPA) in an automated spectrophotometer and three substrates 
(4-nPA, PA, and DC) in a manual spectrophotometer.  
Using paraoxon as substrate, the RIs of dolphins (6.7 ± 4.6 U/L) were lower compared to the RIs of 
dogs (Rossi et al., 2013). Since the PON-1 is a negative APP, the low activity measured in our work 
hampered the possibility to appreciate an additional decrease in diseased animals. One possible 
explanation for the low PON-1 activity using paraoxon as substrate in bottlenose dolphins is the 
lack of the paraoxonase activity of this enzyme and consequently a possible non-specific reaction to 
the substrates. Moreover, PON-1 is an enzyme associated with high density lipoproteins (HDL) that 
protects low density lipoproteins (LDL) and HDL from peroxidation (Aviram et al., 1998; 
Mackness et al., 2004). No data are present regarding the lipid metabolism in marine mammals, so 
we measured the HDL in the serum of the bottlenose dolphins to evaluate if the low activity of 
PON-1 could be explained by a low HDL concentration. The mean concentration in HDL was 
comparable to the concentration of bovine (Crociati et al., 2017), and the evaluation of the PON-1 
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activity in these animals had been performed successfully (Kulka et al., 2014). The different 
evolution of these aquatic mammals and their peculiar environment could lead to a different lipid 
metabolism in dolphins compared to terrestrial mammals, so the enzymes associated to the HDL are 
instable and the measurement can be a challenge.  
In human medicine two SNPs are known to be able to influence the PON-1 activity: when leucine is 
changed with methionine in position 55 (L55M) and/or when glycine is changed with arginine in 
position 192 (Q192R) in the PON-1 gene, the paraoxonase activity of PON-1 is increased 
(Mackness and Mackness, 2015). The coding region of the paraoxon gene was screened for 
alterations by direct sequencing of all samples and all the animals were homozygous for methionine 
in position 55 and for arginine in position 192. Despite all the animals are homozygous for the 
phenotype that in human is associated to a higher paraoxonase activity, the PON-1 bottlenose 
dolphins activity is low. Further study will be focused on the promoter region of the PON-1 gene, 
because in the bovine seven SNPs were identified and five of them are associated with variability in 
serum PON-1 activity (Silveira et al., 2015). Moreover, Mahrooz and colleagues demonstrated that, 
in human with the QR or RR phenotypes in position 192, when the concentration of NaCl in the 
Tris/HCl were increased from 1 mmol to 1 mol, also the PON-1 paraoxonase activity increase 
(Mahrooz et al., 2014). Thus, the salt-stimulated PON-1 paraoxonase activity was evaluated also in 
dolphins, but no differences were evident compared to the normal (with 1mmol NaCl) paraoxonase 
activity (data not shown), despite all the animals were homozygous RR in position 192. This data 
further suggested that the Q192R SNP does not influence the paraoxonase PON-1 activity in 
dophins. 
Since the PON-1 activity using paraoxon as substrate in dolphins is low, other substrates were 
tested, to evaluate if the PON-1 in dolphins could have higher arylesterase or lactonase activity 
rather than paraoxonase activity. The PON-1 activity using 4-nPA as substrate were higher 
compared to those obtained using paroxon, thus more suitable to use as a negative APP. 
Arylesterase activity in bottlenose dolphins appeared to be higher also compared to other animals, 
such as dogs (Tvarijonaviciute et al., 2012) and pigs (Escribano et al., 2015) (186.2 ± 20.4 U/L vs. 
5.32 ± 0.7 U/L and 51.0 ± 16.0 U/L, respectively). Unfortunately, no differences were noted 
between healthy and diseased animals and these data obviously hampered the use of 4-nPA as 
substrate to evaluate the activity of PON-1 as a negative APP to evaluate the health status in 
bottlenose dolphins, differently from what happens in pigs (Escribano et al., 2015). However, our 
results are based on a limited number of animals with toxoplasmosis or that were found stranded 
without a specific disease. We cannot exclude that, including a higher number of animals with 
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different disease (e.g infectious diseases that marked affected immune system in dolphins such as 
morbillivirus), a more drastic change in PON-1 activity will be evident.   
The arylesterase activity using PA and the lactonase activity using DC as substrates could not be 
performed in the automated spectrophotometer due to the lack of instrument with UV laser. The 
PON-1 activity measured using PA provides results with high variability, in 6 tests no reaction were 
evident, and 4 tests provided negative activity. This high variability could be related to the non-
automated procedures for the measurement, which leads to pipetting errors and non-standardized 
time of reading, or to a low stability of the reagents. Therefore, based on these technical limitations, 
it is difficult to properly evaluate if PA could be considered a useful substrate for PON activity. 
Moreover, the possibility to adapt this assay to automated analyser is mandatory for higher 
specimen throughout without any pipetting errors. As regards the lactonase activity using DC, no 
reactions were evident, despite the changing in serum amount and reading time. Consequently, we 
can hypothesize that the dolphin’s PON-1 does not have a lactonase activity. 
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6. CONCLUSIONS 
In the present thesis, new data regarding the serum proteins of odondocetes were provided. 
Firstly, the RIs of the SPE using AGE for under human care dolphins were established. Moreover, 
in 8 samples a wider albumin peak was evident. To investigate this abnormality, CZE were 
performed in all the samples, and in nine of them a double albumin peak was noticed. The visual 
appearance of CZE profiles was different compared to AGE in our samples, as previously reported 
for dogs and cats (Giordano and Paltrinieri, 2010). The differences between CZE and AGE profiles 
likely resulted from the different analytical principle of the two methods and from the higher 
resolution of CZE (Giordano and Paltrinieri, 2010). The application of higher resolution techniques, 
such as CZE, can result in an increased number of ‘’abnormal’’ profiles, and thus the knowledge 
that the CZE profiles are different from the AGE profiles is important, and training in interpretation 
of CZE data and profiles and more confident interpretations in clinical practice are necessary. Since 
bisalbuminemia was confirmed by CZE analysis, the next step of the study was focused on the 
identification of the mutations responsible and the inheritance pattern of this disorder. We found 
that the albumin gene possessed a significant degree of polymorphisms and we identified two 
mutations potentially responsible of inherited bisalbuminemia, one of this homologs to a mutation 
already reported in human medicine and named Albumin Asola (Minchiotti et al., 1995). Moreover, 
we found that bisalbuminemia was inherited in autosomal codominant manner. 
The second part of the thesis was focused on the study of APPs. Our RIs for the positive APPs were 
different compared to the previously published RIs for bottlenose dolphins (Cray et al., 2013). The 
difference in the two RIs underlines the importance that each laboratory establishes its own RIs. 
Moreover, based on the lack of cross-reactivity demonstrated for the anti-CRP Abs, it is important 
that all the assays developed for new species undergo to a complete validation process, especially 
when immunological assay has to be validated. We determined the RIs for SAA; but it was not 
possible to evaluate this assay in diseased animals, so we could not determine the diagnostic 
accuracy of this assay. Further studies will be focused on the evaluation of the diagnostic 
performance of SAA including diseased animals to determine if the concentration of SAA increases 
in case of infectious pathologies.  
In addition, we evaluated the activity of the negative APP PON-1 in both healthy and diseased 
animals. The tests with paraoxon and 4-nPA as substrates provided results that have good precision. 
The paraoxonase assay was tested only in healthy animals, but due to the low activity demonstrated, 
it seems that this assay could not be used to discriminate between healthy and diseased animals.  
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The arylesterase activity of PON-1 was evaluated in both healthy and diseased animals. 
Unfortunately, no differences were noted between healthy and diseased animals and these data 
obviously hampered the use of  4-nPA as substrate to evaluate the activity of PON-1 as a negative 
APP, differently from what happens in pigs (Escribano et al., 2015). However, our results are based 
on a limited number of animals that were found stranded without a specific disease. We cannot 
exclude that, including a higher number of animals with diseases which markedly affected immune 
system a more drastic change in PON activity will be evident. 
  
75 
 
References 
Andrésdóttir V., Magnadóttir B., Andrésson O.S., Pétursson G., 1987. Subclasses of IgG from 
whales. Dev. Comp. Immunol. 11, 801–806. 
Antonsson A., Hansson B.G., 2002. Healthy skin of many animal species harbors papillomaviruses 
which  are closely related to their human counterparts. J. Virol. 76, 12537–12542.  
Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., La Du, B.N., 1998. 
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: A possible 
peroxidative role for paraoxonase. J. Clin. Invest. 101, 1581–1590.  
Beineke A., Siebert U., Müller G., Baumgärtner W., 2007. Increased blood interleukin-10 mRNA 
levels in diseased free-ranging harbor porpoises (Phocoena phocoena). Vet. Immunol. 
Immunopathol. 115, 100–106.  
Beineke A., Siebert U., van Elk N., Baumgärtner W., 2004. Development of a lymphocyte-
transformation-assay for peripheral blood lymphocytes of the harbor porpoise and detection of 
cytokines using the reverse-transcription polymerase chain reaction. Vet. Immunol. 
Immunopathol. 98, 59–68. 
Beineke A., Siebert U., Wohlsein P., Baumgärtner W., 2010. Immunology of whales and dolphins. 
Vet. Immunol. Immunopathol. 133, 81–94.  
Blackburn W.D., 1994. Validity of acute phase proteins as markers of disease activity. J. 
Rheumatol. 21, 9–13. 
Bonsembiante F., Centelleghe C., Rossi G., Giglio S., Madeo E., Gelain, M. E., Mazzariol S., 2017. 
Clinico-pathological findings in a striped dolphin (Stenella coeruleoalba) affected by 
rhabdomyolysis and myoglobinuric nephrosis (capture myopathy). J. Vet. Med. Sci. In Press 
Bossart G.D., Reidarson T.H., Dierauf L.A., Duffield D.A., 2001. Clinical Pathology, in: Dierauf, 
L.A., Gulland, F.M.D. (Eds.), CRC Handbook of Marine Mammal Medicine. CRC Press, Boca 
Raton, FL, USA. pp. 383–436. 
Bossuyt X., 2006. Advances in Serum Protein Electrophoresis. Adv. Clin. Chem. 42, 43–80. 
Bossuyt X., 2003. Separation of serum proteins by automated capillary zone electrophoresis. Clin. 
Chem. Lab. Med. 41, 762–772. 
76 
 
Bossuyt X., Lissoir B., Mariën G., Maisin D., Vunckx J., Blanckaert N., Wallemacq P., 2003. 
Automated serum protein electrophoresis by Capillarys. Clin. Chem. Lab. Med. 41, 704–710.  
Browne R.W., Koury S.T., Marion S., Wilding G., Muti P., Trevisan M., 2007. Accuracy and 
biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by 
kinetic enzyme assay. Clin. Chem. 53, 310–317. 
Bürger W., Fennert E.M., Pohle M., Wesemeier H., 1992. C-reactive protein: a characteristic 
feature of health control in swine. Zentralbl. Veterinarmed. A. 39, 635–638. 
Burnette W.N., 1981. Western blotting: electrophoretic transfer of proteins from sodium dodecyl 
sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with 
antibody and radioiodinated protein A. Anal. Biochem. 112, 195–203. 
Caspi D., Snel F.W., Batt R.M., Bennett D., Rutteman G.R., Hartman E.G., Baltz M.L., Gruys E., 
Pepys M.B., 1987. C-reactive protein in dogs. Am. J. Vet. Res. 48, 919–921. 
Cassatella M.A., 1995. The production of cytokines by polymorphonuclear neutrophils. Immunol. 
Today 16, 21–26.  
Cavagnolo R.Z., 1979. The immunology of marine mammals. Dev. Comp. Immunol. 3, 245–57. 
Cerón J.J., Eckersall P.D., Martínez-Subiela S., 2005. Acute phase proteins in dogs and cats: 
Current knowledge and future perspectives. Vet. Clin. Pathol. 34, 85–99.  
Christensen M., Jacobsen S., Ichiyanagi T., Kjelgaard-Hansen M., 2012. Evaluation of an 
automated assay based on monoclonal anti-human serum amyloid A (SAA) antibodies for 
measurement of canine, feline, and equine SAA. Vet. J. 194, 332–337.  
Christensen M.B., Eriksen T., Kjelgaard-Hansen M., 2015. C-reactive protein: quantitative marker 
of surgical trauma and post-surgical complications in dogs: a systematic review. Acta Vet. 
Scand. 57, 71.  
Colgrove G.S., 1978. Stimulation of lymphocytes from a dolphin (Tursiops truncatus) by 
phytomitogens. Am. J. Vet. Res. 39, 141–144. 
Costa L.G., Vitalone A., Cole T.B., Furlong C.E., 2005. Modulation of paraoxonase (PON1) 
activity. Biochem. Pharmacol. 69, 540-541. 
Corbel M.J., 1997. Brucellosis: An Overview. Emerg. Infect. Dis. 3, 213–221.  
Cray C., 2012. Acute Phase Proteins in Animals. Prog. Mol. Biol. Transl. Sci. 105, 113-150. 
77 
 
Cray C., Arheart K.L., Hunt M., Clauss T., Leppert L.L., Roberts K., McCulloch S.D., Goldstein 
J.D., Gonzalez C., Sweeney J., Stone R., Fair P.A., Bossart G.D., 2013. Acute phase protein 
quantitation in serum samples from healthy Atlantic bottlenose dolphins (Tursiops truncatus). 
J. Vet. diagnostic Investig. 25, 107–111.  
Cray C., Zaias J., Altman N.H., 2009. Acute phase response in animals: a review. Comp. Med. 59, 
517–526.  
Crociati M., Sylla L., Floridi C., Comin A., Fruganti G., Monaci M., Stradaioli G., 2017. Influence 
of lipoproteins at dry-off on metabolism of dairy cows during transition period and on 
postpartum reproductive outcomes. Theriogenology 94, 31–36.  
Dagleish M.P., Barley J., Finlayson J., Reid R.J., Foster G., 2008. Brucella Ceti associated 
pathology in the testicle of a harbour porpoise (Phocoena phocoena). J. Comp. Pathol. 139, 
54–59.  
Davison N.J., Cranwell M.P., Perrett L.L., Dawson C.E., Deaville R., Stubberfield E.J., Jarvis D.S., 
Jepson P.D., 2009. Meningoencephalitis associated with Brucella species in a live-stranded 
striped dolphin (Stenella coeruleoalba) in south-west England. Vet. Rec. 165, 86–89. 
De Guise S., Bernier J., Dufresne M.M., Martineau D., Beland P., Fournier M., 1996. Immune 
functions in beluga whales (Delphinapterus leucas): evaluation of mitogen-induced blastic 
transformation of lymphocytes from peripheral blood, spleen and thymus. Vet. Immunol. 
Immunopathol. 50, 117–126. 
Delpeut S., Noyce R.S., Richardson C.D., 2014. The tumor-associated marker, PVRL4 (Nectin-4), 
is the epithelial receptor for morbilliviruses. Viruses 6, 2268–2286.  
Denis F., Archambault D., 2001. Molecular cloning and characterization of beluga whale 
(Delphinapterus leucas) interleukin-1beta and tumor necrosis factor-alpha. Can. J. Vet. Res. 
65, 233–240. 
Di Guardo G., Agrimi U., Morelli L., Cardeti G., Terracciano G., Kennedy S., 1995. Post mortem 
investigations on cetaceans found stranded on the coasts of Italy between 1990 and 1993. Vet. 
Rec. 136, 439–442. 
Di Guardo G., Mazzariol S., 2016. Cetacean Morbillivirus-associated pathology: Knowns and 
unknowns. Front. Microbiol. 7, 1–5. 
Dinarello C.A., 1989. Interleukin-1 and its biologically related cytokines. Adv. Immunol. 44, 153–
78 
 
205. 
Dinarello C.A., 1983. Pathogenesis of fever during hemodialysis. Adv. Immunol. 36, 90–99. 
Domingo M., Vilafranca M., Visa J., Prats N., Trudgett A., Visser I., 1995. Evidence for chronic 
morbillivirus infection in the Mediterranean striped dolphin (Stenella coeruleoalba). Vet. 
Microbiol. 44, 229–239. 
Draganov D.I., Stetson P.L., Watson C.E., Billecke S.S., La Du B.N., 2000. Rabbit serum 
paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low 
density lipoprotein against oxidation. J. Biol. Chem. 275, 33435–33442.  
Draganov D.I., La Du B.N., 2004. Pharmacogenetics of paraoxonase: a brief review. Neunyn's 
Schmiedeberg's Arch. Pharmacol. 369, 79-88. 
Dubey J.P., Zarnke R., Thomas N.J., Wong S.K., Van Bonn W., Briggs M., Davis J.W., Ewing R., 
Mense M., Kwok O.C., Romand S., Thulliez P., 2003. Toxoplasma gondii, Neospora caninum, 
Sarcocystis neurona, and Sarcocystis canis-like infections in marine mammals. Vet. Parasitol. 
116, 275–296.  
Dupire S., Wemeau M., Debarri H., Pascal L., Hivert B., Willekens C., Boyle E., Manier S., 
Béatrice T., Onraed B., Faucompré J.L., Hennache B., Dumontet C., Facon T., Leleu X., 2012. 
Prognostic value of PINI index in patients with multiple myeloma. Eur. J. Haematol. 88, 306–
313.  
Eckersall P.D., Conner J.G., Harvie J., 1991. An immunoturbidimetric assay for canine C-reactive 
protein. Vet. Res. Commun. 15, 17–24. 
Eckersall P.D., Schmidt E.M.D.S., 2014. The final hurdles for acute phase protein analysis in small 
animal practice. J. Small Anim. Pract. 55, 1–3.  
Ejaz A.A., Krishna M., Wasiluk A., Knight J.D., 2004. Bisalbuminemia in chronic kidney disease. 
Clin. Exp. Nephrol. 8, 270–273.  
Erickson K.L., DiMolfetto-Landen L., Wells R.S., Reidarson T., Stott J.L., Ferrick D.A., 1995. 
Development of an interleukin-2 receptor expression assay and its use in evaluation of cellular 
immune responses in bottlenose dolphin (Tursiops truncatus). J. Wildl. Dis. 31, 142–149. 
Escribano D., Tvarijonaviciute A., Tecles F., Cerón J.J., 2015. Serum paraoxonase type-1 activity in 
pigs: Assay validation and evolution after an induced experimental inflammation. Vet. 
Immunol. Immunopathol. 163, 210–215.  
79 
 
Feingold K.R., Memon R.A., Moser A.H., Grunfeld C., 1998. Paraoxonase activity in the serum 
and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 139, 307–
315.  
Foster G., MacMillan A.P., Godfroid J., Howie F., Ross H.M., Cloeckaert A., Reid R.J., Brew S., 
Patterson I.A.P., 2002. A review of Brucella sp. infection of sea mammals with particular 
emphasis on isolates from Scotland. Vet. Microbiol. 90, 563–580.  
Foster G., Osterman B.S., Godfroid J., Jacques I., Cloeckert A., 2007. Brucella ceti sp. nov. and 
Brucella pinnipedialis sp. nov. for Brucella strains with cetaceans and seals as their preferred 
hosts. Int. J. Syst. Evol. Microbiol. 57, 2688–2693.  
Friedrichs K.R., Harr K.E., Freeman K.P., Szladovits B., Walton R.M., Barnhart K.F., Blanco-
Chavez J., 2012. ASVCP reference interval guidelines: Determination of de novo reference 
intervals in veterinary species and other related topics. Vet. Clin. Pathol. 41, 441–453. 
Funke C., King D.P., Brotheridge R.M., Adelung D., Stott J.L., 1997. Harbor seal (Phoca vitulina) 
C-reactive protein (C-RP): Purification, characterization of specific monoclonal antibodies and 
development of an immuno-assay to measure serum C-RP concentrations. Vet. Immunol. 
Immunopathol. 59, 151–162.  
Galliano M., Kragh-Hansen U., Tárnoky A.L., Chapman J.C., Campagnoli M., Minchiotti L., 1999. 
Genetic variants showing apparent hot-spots in the human serum albumin gene. Clin. Chim. 
Acta 289, 45–55.  
Galliano M., Minchiotti L., Porta F., Rossi A., Ferri G., Madison J., Watkins S., Putnam F.W., 
1990. Mutations in genetic variants of human serum albumin found in Italy. Proc. Natl. Acad. 
Sci. 87, 8721. 
Garg R.K., 2008. Subacute sclerosing panencephalitis. J. Neurol. 255, 1861–1871.  
Geffré A., Concordet D., Braun J.P., Trumel C., 2011. Reference Value Advisor: a new freeware set 
of macroinstructions to calculate reference intervals with Microsoft Excel. Vet. Clin. Pathol. 
40, 107–112.  
Giordano A., Paltrinieri S., 2010. Interpretation of capillary zone electrophoresis compared with 
cellulose acetate and agarose gel electrophoresis: reference intervals and diagnostic efficiency 
in dogs and cats. Vet. Clin. Pathol. 39, 464–473.  
Goldstein J.D., Reese E., Reif J.S., Varela R.A., McCulloch S.D., Defran R.H., Fair P.A., Bossart 
80 
 
G.D., Hansen L., 2006. Hematologic, biochemical, and cytologic findings from apparently 
healthy atlantic bottlenose dolphins (Tursiops truncatus) inhabiting the Indian River Lagoon, 
Florida, USA. J. Wildl. Dis. 42, 447–54.  
González L., Patterson I.A., Reid R.J., Foster G., Barberán M., Blasco J.M., Kennedy S., Howie 
F.E., Godfroid J., MacMillan A.P., Schock A., Buxton D., 2002. Chronic meningoencephalitis 
associated with Brucella sp. infection in live-stranded striped dolphins (Stenella coeruleoalba). 
J. Comp. Pathol. 126, 147–152.  
Gopaul K.P., Crook M.A., 2006. Sialic acid: a novel marker of cardiovascular disease? Clin. 
Biochem. 39, 667–681. 
Groussaud P., Shankster S.J., Koylass M.S., Whatmore A.M., 2007. Molecular typing divides 
marine mammal strains of Brucella into at least three groups with distinct host preferences. J. 
Med. Microbiol. 56, 1512–1518.  
Gruys E., Obwolo M.J., Toussaint M.J.M., 1994. Diagnostic significance of the major acute acute 
phase proteins in veterinary clinical chemistry: a review. Vet. Bull. 64, 1009–1018. 
Gruys E., Toussaint M.J.M., Niewold T.A., Koopmans S.J., 2005. Acute phase reaction and acute 
phase proteins. J. Zhejiang. Univ. Sci. B 6, 1045–1056.  
Gruys E., Toussaint M.J.M., Niewold T.A., Koopmans S.J., van Dijk E., Meloen R.H., 2006. 
Monitoring health by values of acute phase proteins. Acta Histochem. 108, 229–232.  
Harr K., Harvey J., Bonde R., Murphy D., Lowe M., Menchaca M., Haubold E., Francis-Floyd R., 
2006. Comparison of methods used to diagnose generalized inflammatory disease in manatees 
(Trichechus manatus latirostris). J. Zoo Wildl. Med. 37, 151–159. 
Headley S.A., Amude A.M., Alfieri A.F., Bracarense A.P.F.R.L., Alfieri A.A, Summers B.A., 
2009. Molecular detection of Canine distemper virus and the immunohistochemical 
characterization of the neurologic lesions in naturally occurring old dog encephalitis. J. Vet. 
Diagn. Invest. 21, 588–597.  
Hernández-Mora G., González-Barrientos R., Morales J.A., Chaves-Olarte E., Guzmán-Verri C., 
Baquero-Calvo E., De-Miguel M.J., Marín C.M., Blasco J.M., Moreno E., 2008. 
Neurobrucellosis in stranded dolphins, Costa Rica. Emerg. Infect. Dis. 14, 1430–1433.  
Hijmans W., Sipe J.D., 1979. Levels of the serum amyloid A protein (SAA) in normal persons of 
different age groups. Clin. Exp. Immunol. 35, 96–100. 
81 
 
Hillström A., Tvedten H., Lilliehöök I., 2010. Evaluation of an in-clinic Serum Amyloid A (SAA) 
assay and assessment of the effects of storage on SAA samples. Acta Vet. Scand. 52, 8. 
 Horn P.S., Pesce A.J., Copeland B.E., 1998. A robust approach to reference interval estimation and 
evaluation. Clin. Chem. 44, 622-631. 
Horn P.S., Pesce A.J., 2003. Reference intervals. Clin. Chim. Acta. 334, 5-23. 
Howley P.M., Lowry D.R., 2001. Papillomaviruses and their replication, in: Knipe, D.M., Howley, 
P.M. (Eds.), Fields Virology. Lippincott Williams & Wilkins, Philadelphia, pp. 2197–2230. 
Hultén C., Sletten K., Foyn Bruum C., Marhaug G., 1997. The acute phase serum amyloid A (SAA) 
in the horse: isolation and characterisation of three isoforms. Vet. Immunol. Immunopathol. 57, 
215-227. 
Ingenbleek M., Young V., 1994. Transthyretin (prealbumin) in health and disease: nutritional 
implications. Ann. Rev. Nutr. 14, 495–533. 
Isaza R., Wiedner E., Hiser S., Cray C., 2014. Reference intervals for acute phase protein and serum 
protein electrophoresis values in captive Asian elephants (Elephas maximus). J. Vet. Diagn. 
Invest. 26, 616-621. 
Jaeggi-Groisman S.E., Boyland C., Gerber H., 2000. Improved sensitivity of capillary 
electrophoresis for detection of bisalbuminemia. Clin Chem. 46, 882–883. 
Jaye D.L., Waites K.B., 1997. Clinical applications of C-reactive protein in pediatrics. Pediatr. 
Infect. Dis. J. 16, 735-746. 
Johnson H.L., Chiou C.C., Cho C.T., 1999. Applications of acute phase reactants in infectious 
diseases. J. Microbiol. Immunol. Infect. 32, 73–82. 
Jones D.T., 1999. Protein secondary structure prediction based on position-specific scoring 
matrices. J. Mol. Biol. 292, 195–202.  
Kakuschke A., Erbsloeh H.B., Griesel S., Prange A., 2010. Acute phase protein haptoglobin in 
blood plasma samples of harbour seals (Phoca vitulina) of the Wadden Sea and of the isle 
Helgoland. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 155, 67–71.  
Kalambokis G., Kitsanou M., Kalogera C., Kolios G., Seferiadis K., Tsianos E., 2002. Inherited 
bisalbuminemia with benign monoclonal gammopathy detected by capillary but not agarose 
gel electrophoresis. Clin. Chem. 48, 2076–2077. 
82 
 
Kent J., 1992. Acute phase proteins: their use in veterinary diagnosis. Br. Vet. J. 148, 279–282.  
Khoshi A., Mortazavi Y., Akbari A., Sokhanvar S., Kalantari S., 2009. Relationship between 
PON1L55M and Q192R gene polymorphisms and high APO B/APO A-I ratios. Indian J. Clin. 
Biochem. 24, 381–387. 
King D.P., Aldrige B.M., Kennedy-Stoskopf S., Stott J.L., 2001. Immunology, in: Dierauf, L.A., 
Gulland, F.M.D. (Eds.), CRC Handbook of Marine Mammal Medicine. CRC Press, Boca 
Raton, FL, USA,  pp. 237–252. 
King D.P., Schrenzel M.D., McKnight M.L., Reidarson T.H., Hanni K.D., Stott J.L., Ferrick D.A., 
1996. Molecular cloning and sequencing of interleukin 6 cDNA fragments from the harbor seal 
(Phoca vitulina), killer whale (Orcinus orca), and Southern sea otter (Enhydra lutris nereis). 
Immunogenetics 43, 190–195. 
Kjelgaard-Hansen M., Jacobsen S., 2011. Assay validation and diagnostic applications of major 
acute-phase protein testing in companion animals. Clin. Lab. Met. 31, 51-70. 
Kjelgaard-Hansen M., Mikkelsen L.F., Kristensen A.T., Jensen A.L., 2003. Study on biological 
variability of five acute-phase reactants in dogs. Comp. Clin. Path. 12, 69–74.  
Klenner S., Bauer N., Moritz A., 2010. Evaluation of three automated human immunoturbidimetric 
assays for the detection of C-reactive protein in dogs. J. Vet. Diagnostic Investig. 22, 544–552.  
Koj A., 1996. Initiation of acute phase response and synthesis of cytokines. Biochim. Biophys. Acta 
1317, 84–94.  
Kragh-Hansen U., Minchiotti L., Galliano M., Peters T., 2013. Human serum albumin isoforms: 
genetic and molecular aspects and functional consequences. Biochim. Biophys. Acta 1830, 
5405–5417.  
Kulka M., Beltowski J., Klucinski W., Orlowska M., Kolodziejska J., Kleczkowski M., 2014. 
Serum paraoxonase-1 activity of dairy Holstein-Fresian cows in different lactation stages-
preliminary study. Pol. J. Vet. Sci. 17, 143–147. 
Kushner I., Gewurz H., Benson M.D., 1981. C-reactive protein and the acute-phase response. J. 
Lab. Clin. Med. 97, 739–749. 
Laemmli U.K., 1970. Cleavage of structural proteins during assembly of head of bacteriophageT4. 
Nature 227, 680–685.  
83 
 
Lahvis G.P., Wells R.S., Casper D., Via C.S., 1993. In-vitro lymphocyte response of bottlenose 
dolphins (Tursiops truncatus): mitogen-induced proliferation. Mar. Environ. Res. 35, 115–119. 
Ludlow M., McQuaid S., Milner D., De Swart R.L.D., Duprex W.P., 2015. Pathological 
consequences of systemic measles virus infection. J. Pathol. 235, 253–265.  
Lundqvist M.L., Kohlberg K.E., Gefroh H.A., Arnaud P., Middleton D.L., Romano T.A., Warr 
G.W., 2002. Cloning of the IgM heavy chain of the bottlenose dolphin (Tursiops truncatus), 
and initial analysis of VH gene usage. Dev. Comp. Immunol. 26, 551–562.  
Mackness B., Hine D., Liu Y., Mastorikou M., Mackness M., 2004. Paraoxonase-1 inhibits oxidised 
LDL-induced MCP-1 production by endothelial cells. Biochem. Biophys. Res. Commun. 318, 
680–683.  
Mackness M., Mackness B., 2015. Human paraoxonase-1 (PON1): gene structure and expression, 
promiscuous activities and multiple physiological roles. Gene 567, 12–21.  
Mahrooz A., Alizadeh A., Gohari G., 2014. The salt stimulation property of serum paraoxonase 
(PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role 
of activity-determined PON1 192Q/R phenotypes. J. Neurol. Sci. 338, 197–202.  
Mancia A., Romano T.A., Gefroh H.A., Chapman R.W., Middleton D.L., Warr G.W., Lundqvist 
M.L., 2007. Characterization of the immunoglobulin A heavy chain gene of the Atlantic 
bottlenose dolphin (Tursiops truncatus). Vet. Immunol. Immunopathol. 118, 304–309.  
Mancia A., Romano T.A., Gefroh H.A., Chapman R.W., Middleton D.L., Warr G.W., Lundqvist 
M.L., 2006. The Immunoglobulin G Heavy Chain (IGHG) genes of the Atlantic bottlenose 
dolphin, Tursiops truncatus. Comp. Biochem. Physiol. 144, 38–46.  
Manire C.A., Rhinehart H.L., 2000. Use of human recombinant erythropoietin for the treatment of 
nonregenerative anemia in a rough-toothed dolphin (Steno Bredanensis). J. Zoo Wildl. Med. 
31, 157–163.  
Maruna P., Gürlich R., Frasko R., Rosicka M., 2005. Ghrelin and leptin elevation in postoperative 
intra-abdominal sepsis. Eur. Surg. Res. 37, 354–359.  
Matijatko V., Mrljak V., Kis I., Kucer N., Forsek J., Zivicnjak T., Romic Z., Simec, Z., Ceron, J.J., 
2007. Evidence of an acute phase response in dogs naturally infected with Babesia canis. Vet. 
Parasitol. 144, 242–250. 
McGrotty Y.L., Knottenbelt C.M., Ramsey I.K., Reid S.W.J., Eckersall P.D., 2003. Haptoglobin 
84 
 
concentrations in a canine hospital population. Vet. Rec. 152, 562–564. 
Miller M.A., Miller W.A., Conrad P.A., James E.R., Melli A.C., Leutenegger C.M., Dabritz H.A., 
Packham A.E., Paradies D., Harris M., Ames J., Jessup D.A., Worcester K., Grigg M.E., 2008. 
Type X Toxoplasma gondii in a wild mussel and terrestrial carnivores from coastal California: 
New linkages between terrestrial mammals, runoff and toxoplasmosis of sea otters. Int. J. 
Parasitol. 38, 1319–1328.  
Minchiotti L., Galliano M., Kragh-Hansen U., Peters T., 2008. Mutations and polymorphisms of the 
gene of the major human blood protein, serum albumin. Hum. Mutat. 29, 1007–1016.  
Minchiotti L., Galliano M., Kragh-Hansen U., Watkins S., Madison J., Putnam F.W., 1995. A 
genetic variant of albumin ( albumin Asola ; Tyrl4OGCys ) with no free -SH group but with an 
additional disulfide bridge. Eur. J. Biochem. 228, 155–159. 
Minghetti P.P., Ruffners D.E., Kuangs W., Dennison O.E, Hawkins J.W., Beattie W.G., Dugaiczyk 
A., 1986. Molecular structure of the human albumin gene is revealed by nucleotide sequence 
within 911-22 of chromosome 4. J. Biol. Chem. 261, 6747–6757. 
Murata H., Shimada N., Yoshioka M., 2004. Current research on acute phase proteins in veterinary 
diagnosis: an overview. Vet. J. 168, 28–40.  
Nash D.R., Mach J.-P., 1971. Immunoglobin classes in aquatic mammals-Characterization by 
serologic cross-reactivity, molecular size and binding of human free secretory component. J. 
Immunol. 107, 1424–1430. 
Nielsen H., Kragh-Hansen U., Minchiotti L., Galliano M., Brennan S.O., Tárnoky A.L., Franco 
M.H., Salzano F.M., Sugita O., 1997. Effect of genetic variation on the fatty acid-binding 
properties of human serum albumin and proalbumin. Biochim. Biophys. Acta 1342, 191–204.  
Noda K., Aoki M., Akiyoshi H., Asaki H., Ogata T., Yamauchi K., Shimada T., Ohashi F., 2006. 
Effect of bovine lactoferrin on the immune responses of captive bottlenosed dolphins (Tursiops 
truncates) being transported over long distances. Vet. Rec. 159, 885–888. 
Noda K., Aoki M., Akiyoshi H., Asaki H., Shimada T., Ohashi F., 2003. Evaluation of the 
polymorphonuclear cell functions of bottlenose dolphins. J. Vet. Med. Sci. 65, 727–729. 
Nollens H.H., Green L.G., Duke D., Walsh M.T., Chittick B., Gearhart S., Klein P.A., Jacobson 
E.R., 2007. Development and validation of monoclonal and polyclonal antibodies for the 
detection of immunoglobulin G of bottlenose dolphins (Tursiops truncatus). J. Vet. Diagn. 
85 
 
Invest. 19, 465–470.  
Nunokawa Y., Fujinaga T., Taira T., Okumura M., Yamashita K., Tsunoda N., Hagio M., 1993. 
Evaluation of serum amyloid A proteins as an acute-phase reactive protein in horses. J. Vet. 
Med. Sci. 55, 1011-1016. 
Osterhaus A.D., de Swart R.L., Vos H.W., Ross P.S., Kenter M.J., Barrett T., 1995. Morbillivirus 
infections of aquatic mammals: newly identified members of the genus. Vet. Microbiol. 44, 
219–427. 
Otabe K., Ito T., Sugimoto T., Yamamoto S., 2000. C-reactive protein (CRP) measurement in 
canine serum following experimentally-induced acute gastric mucosal injury. Lab. Anim. 34, 
434–438. 
Owen-Ashley N.T., Turner M., Hahn T.P., Wingfield J.C., 2006. Hormonal, behavioral, and 
thermoregulatory responses to bacterial lipopolysaccharide in captive and free-living white-
crowned sparrows (Zonotrichia leucophrys gambelii). Horm. Behav. 49, 15–29.  
Paltrinieri S., 2008. The feline acute phase reaction. Vet. J. 177, 26–35.  
Pepys M.B., Baltz M.L., 1983. Acute phase proteins with special reference to C-reactive protein 
and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34, 141–212. 
Pepys M.B., Baltz M.L., Tennent G.A., Kent P.J.E., Ousey J., Rossdale P.D., 1989. Serum amyloid 
A protein (SAA) in horses: objective measurement of the acute phase response. Equine Vet. J. 
21, 106–109.  
Petersen C.E., Scottolini A.G., Cody L.R., Mandel M., Reimer N., Bhagavan N. V, 1994. A point 
mutation in the human serum albumin gene results in familial dysalbuminaemic 
hyperthyroxinaemia. J. Med. Genet. 31, 355–359.  
Petersen H.H., Nielsen J.P., Heegaard P.M.H., 2004. Application of acute phase protein 
measurements in veterinary clinical chemistry. Vet. Res. 35, 163–187.  
Rector A., Stevens H., Lacave G., Lemey P., Mostmans S., Salbany A., Vos M., Van Doorslaer K., 
Ghim S.J., Rehtanz M., Bossart G.D., Jenson A.B., Van Ranst M., 2008. Genomic 
characterization of novel dolphin papillomaviruses provides indications for recombination 
within the Papillomaviridae. Virology 378, 151–161.  
Rikihisa Y., Yamamoto S., Kwak I., Iqbal Z., Kociba G., Mott J., Chichanasiriwithaya W., 1994. C-
reactive protein and α1-acid glycoprotein levels in dogs infected with Ehrlichia canis. J. Clin. 
86 
 
Microbiol. 32, 912–917.  
Rosenfeld H., Lassen S., Prange A., 2009. Characterization of haptoglobin in the blood plasma of 
harbor seals ( Phoca vitulina). J. Proteome Res. 8, 2923–2932. 
Rossi G., Giordano A., Pezzia F., Kjelgaard-Hansen M., Paltrinieri S., 2013. Serum paraoxonase 1 
activity in dogs: preanalytical and analytical factors and correlation with C-reactive protein and 
alpha-2-globulin. Vet. Clin. Pathol. 42, 329-341.  
Rossi G., Kulěs J., Rafaj R.B., Mrljak V., Lauzi S., Giordano A., Paltrinieri S., 2014. Relationship 
between paraoxonase 1 activity and high density lipoprotein concentration during naturally 
occurring babesiosis in dogs. Res. Vet. Sci. 97, 318-324. 
Rothkrantz-Kos S., Van Dieijen-Visser M.P., Mulder P.G.H., Drent M., 2003. Potential usefulness 
of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin. 
Chem. 49, 1510–1517.  
Ruiz C.L., Nollens H.H., Venn-Watson S., Green L.G., Wells R.S., Walsh M.T., Nolan E.C., 
McBain J.F., Jacobson E.R., 2009. Baseline circulating immunoglobulin G levels in managed 
collection and free-ranging bottlenose dolphins (Tursiops truncatus). Dev. Comp. Immunol. 33, 
449–455.  
Sanders B.J., Kim D.C., Dunn R.C., 2016. Recent advances in microscale western blotting. Anal. 
Methods 8, 7002-7013.  
Sasaki K., Ma Z., Khatlani T.S., Okuda M., Inokuma H., Onishi T., 2003. Evaluation of feline 
serum amyloid A (SAA) as an inflammatory marker. J. Vet. Med. Sci. 65, 545–548. 
Schrödl W., Büchler R., Wendler S., Reinhold P., Muckova P., Reindl J., Rhode H., 2016. Acute 
phase proteins as promising biomarkers: perspectives and limitations for human and veterinary 
medicine. Proteomics Clin. Appl. 10, 1077-1092. 
Schwacke L.H., Hall A.J., Townsend F.I., Wells R.S., Hansen L.J., Hohn A.A., Bossart G.D., Fair 
P.A., Rowles T.K., 2009. Hematologic and serum biochemical reference intervals for free-
ranging common bottlenose dolphins (Tursiops truncatus) and variation in the distributions of 
clinicopathologic values related to geographic sampling site. Am. J. Vet. Res. 70, 973–985.  
Segawa T., Otsuka T., Itou T., Suzuki M., Karatani N., Sakai T., 2013. Characterization of the 
circulating serum amyloid A in bottlenose dolphins. Vet. Immunol. Immunopathol. 152, 218–
224. 
87 
 
Shiraishi R., Itou T., Sugisawa H., Shoji Y., Endo T., Sakai T., 2002. The respiratory burst activity 
of bottlenose dolphin neutrophils elicited by several stimulants. J. Vet. Med. Sci. 64, 711-714. 
Silveira P.A., Schwegler E., Montagner P., Krause A.R., Acosta D.A., Halfen J., Garlet T., Barros 
C.C., Corrêa M.N., Schneider A., 2015. Characterization of single nucleotide polymorphisms 
in the promoter region of the bovine paraoxonase 1 (PON1) gene affecting serum enzyme 
activity in dairy cows. Vet. J. 205, 101–103.  
Sitt T., Bowen L., Blanchard M.T., Smith B.R., Gershwin L.J., Byrne B.A., Stott J.L., 2008. 
Quantitation of leukocyte gene expression in cetaceans. Dev. Comp. Immunol. 32, 1253–1259.  
Smith A.W., Skilling D.E., Ridgway S., 1983. Calicivirus-induced vesicular disease in cetaceans 
and probable interspecies transmission. J. Am. Vet. Med. Assoc. 183, 1223–1225. 
Solter P.F., Hoffmann W.E., Hungerford L.L., Siegel J.P., St Denis S.H., Dorner J.L., 1991. 
Haptoglobin and ceruloplasmin as determinants of inflammation in dogs. Am. J. Vet. Res. 52, 
1738–1742. 
Soto S., Alba A., Ganges L., Vidal E., Raga J.A., Alegre F., González B., Medina P., Zorrilla I., 
Martínez J., Marco A., Perez M., Perez B., Perez De Vargas Mesas A., Valverde R.M., 
Domingo M., 2011. Post-epizootic chronic dolphin morbillivirus infection in Mediterranean 
striped dolphins Stenella coeruleoalba. Dis. Aquat. Organ. 96, 187–194.  
St-Laurent G., Archambault D., 2000. Molecular cloning, phylogenetic analysis and expression of 
beluga whale (Delphinapterus leucas) interleukin 6. Vet. Immunol. Immunopathol. 73, 31–44.  
St-Laurent G., Béliveau C., Archambault D., 1999. Molecular cloning and phylogenetic analysis of 
beluga whale (Delphinapterus leucas) and grey seal (Halichoerus grypus) interleukin 2. Vet. 
Immunol. Immunopathol. 67, 385–394. 
Stockham S., Scott M.A., 2008(a). Introductory concepts, in: Stockham, S., Scott, M.A. (Eds.), 
Fundamentals of Veterinary Clinical Pathology. Blackwell Publishing, Oxford, UK, pp. 4–51. 
Stockham S., Scott M.A., 2008(b). Proteins, in: Stockham, S., Scott, M.A. (Eds.), Fundamentals of 
Veterinary Clinical Pathology. Blackwell Publishing, Oxford, UK, pp. 370–405. 
Taylor B.C., Brotheridge R.M., Jessup D.A., Stott J.L., 2002. Measurement of serum 
immunoglobulin concentration in killer whales and sea otters by radial immunodiffusion. Vet. 
Immunol. Immunopathol. 89, 187–195.  
Thompson D., Pepys M.B., 1999. The physiological struscture of human C-reactive protein and its 
88 
 
complex with phosphocholine. Structure. 7, 169-177. 
Tóthová C., Nagy O., Seidel H., Kováč G., 2012. The effect of storage temperature and time on the 
concentrations of bovine serum amyloid A and its mammary associated isoform. Vet. Med. Int. 
2012, 861458. 
Toussaint M.J.M., van Ederen A.M., Gruys E., 1995. Implication of clinical pathology in 
assessment of animal health and in animal production and meat inspection. Comp. Haematol. 
Int. 5, 149–157.  
Travis J.C., Sanders B.G., 1972. Whale immunoglobulins. II. Heavy chain structure. Comp. 
Biochem. Physiol. B. 43, 637–641. 
Tvarijonaviciute A., Tecles F., Caldin M., Tasca S., Cerón J.J., 2012. Validation of 
spectrophotometric assays for serum paraoxonase type-1 measurement in dogs. Am. J. Vet. 
Res. 73, 34–41. 
Uhlar C.M., Whitehead A.S., 1999. Serum amyloid A, the major vertebrate acute-phase reactant. 
Eur. J. Biochem. 265, 501–523.  
Van Bressem M.-F., Duignan P., Banyard A., Barbieri M., Colegrove K., De Guise S., Di Guardo 
G., Dobson A., Domingo M., Fauquier D., Fernandez A., Goldstein T., Grenfell B., Groch K., 
Gulland F., Jensen B., Jepson P.D., Hall A., Kuiken T., Mazzariol S., Morris S., Nielsen O., 
Raga J., Rowles T., Saliki J., Sierra E., Stephens N., Stone B., Tomo I., Wang J., Waltzek T., 
Wellehan J., 2014. Cetacean Morbillivirus: Current Knowledge and Future Directions. Viruses 
6, 5145–5181.  
Van Bressem M.F., Raga J.A., Di Guardo G., Jepson P.D., Duignan P.J., Siebert U., Barrett T., 
Santos M.C., Moreno I.B., Siciliano S., Aguilar A., Van Waerebeek K., 2009. Emerging 
infectious diseases in cetaceans worldwide and the possible role of environmental stressors. 
Dis. Aquat. Organ. 86, 143–157.  
Van Bressem M.F., Gaspar R., Aznar F.J., 2003. Epidemiology of tattoo skin disease in bottlenose 
dolphins (Tursiops truncatus) from the Sado estuary, Portugal. Dis. Aquat. Organ. 56, 171–
179.  
Van Bressem M.F., Van Waerebeek K., Aznar F.J., Raga J.A., Jepson P.D., Duignan P., Deaville 
R., Flach L., Viddi F., Baker J.R., Di Beneditto A.P., Echegaray M., Genov T., Reyes J., Felix 
F., Gaspar R., Ramos R., Peddemors V., Sanino G.P., Siebert U., 2009. Epidemiological 
pattern of tattoo skin disease: A potential general health indicator for cetaceans. Dis. Aquat. 
89 
 
Organ. 85, 225–237.  
Van Bressem M.F., Van Waerebeek K., Raga J.A., 1999. A review of virus infections of cataceans 
and the potential impact of morbilliviruses, poxviruses and papillomaviruses on host 
population dynamics. Dis. Aquat. Organ. 38, 53–65.  
Wijnen P.A., van Dieijen-Visser M.P., 1996. Capillary electrophoresis of serum proteins. 
Reproducibility, comparison with agarose gel electrophoresis and a review of the literature. 
Eur. J. Clin. Chem. Clin. Biochem. 34, 535–545.  
Yamamoto S., Shida T., Miyaji S., Santsuka H., Fujise H., Mukawa K., Furukawa E., Nagae T., 
Naiki M., 1993. Changes in serum C-reactive protein levels in dogs with various disorders and 
surgical traumas. Vet. Res. Commun. 17, 85–93. 
Yamamoto S., Shida T., Okimura T., Otabe K., Honda M., Ashida Y., Furukawa E., Sarikaputi M., 
Naiki M., 1994. Determination of C-reactive protein in serum and plasma from healthy dogs 
and dogs with pneumonia by ELISA and slide reversed passive latex agglutination test. Vet. Q. 
16, 74–77.  
Yuki M., MacHida N., Sawano T., Itoh H., 2011. Investigation of serum concentrations and 
immunohistochemical localization of α1-acid glycoprotein in tumor dogs. Vet. Res. Commun. 
35, 1–11.  
Yule T.D., Roth M.B., Dreier K., Johnson A.F., Palmer-Densmore M., Simmons K., Fanton R., 
1997. Canine parvovirus vaccine elicits protection from the inflammatory and clinical 
consequences of the disease. Vaccine 15, 720–729.  
  
90 
 
List of original publications regarding the Ph.D project 
1. Gili C., Bonsembiante F., Bonanni R., Giordano A., Ledda S., Beffagna G., Paltrinieri S., 
Sommer M., Gelain M.E. Detection of hereditary bisalbuminemia in bottlenose dolphins 
(Tursiops truncatus, Montagu 1821): comparison between capillary zone and agarose gel 
electrophoresis. BMC Vet Res. 2016; 12:172. 
Abstract. Hereditary bisalbuminemia is a relatively rare anomaly characterized by the 
occurrence of two albumin fractions on serum protein separation by electrophoresis. In human 
medicine, it is usually revealed by chance, is not been clearly associated with a specific disease 
and the causative genetic alteration is a point mutation of human serum albumin gene inherited 
in an autosomal codominant pattern. This type of alteration is well recognizable by capillary 
zone electrophoresis (CZE), whilst agarose gel electrophoresis (AGE) not always produces a 
clear separation of albumin fractions. The aims of this study is to report the presence of this 
abnormality in two separate groups of related bottlenose dolphins and to compare the results 
obtained with capillary zone and agarose gel electrophoresis. Serum samples from 40 
bottlenose dolphins kept under human care were analyzed. In 9 samples a double albumin peak 
was evident in CZE electrophoresis while no double peak was noted in AGE profile. Since only 
an apparently wider albumin peaks were noted in some AGE electrophoretic profiles, the ratio 
between base and height (b/h) of the albumin peak was calculated and each point-value 
recorded in the whole set of data was used to calculate a receiver operating characteristic 
curve: when the b/h ratio of albumin peak was equal or higher than 0.25, the sensitivity and 
specificity of AGE to detect bisalbuminemic samples were 87 and 63 %, respectively. The 
bisalbuminemic dolphins belong to two distinct families: in the first family, all the siblings 
derived from the same normal sire were bisalbuminemic, whereas in the second family 
bisalbuminemia was present in a sire and in two out of three siblings. We report for the first 
time the presence of hereditary bisalbuminemia in two groups of related bottlenose dolphins 
identified by means of CZE and we confirm that AGE could fail in the identification of this 
alteration. 
2. Gili C.*, Bonsembiante F*, Beffagna G, Mazzariol S, Gelain M.E.. Mutations and 
polymorphism in bottlenose dolphin (Tursiops truncatus, Montagu 1821) albumin gene: First 
identification of mutations responsible for inherited bisalbuminemia. Res Vet Sci. 2017; 114:12-
17. (*Gili C. and Bonsembiante F. equally contributed to this article). 
Abstract. Hereditary bisalbuminemia is an asymptomatic and heterozygous condition in a range 
of species characterized by the presence of two serum albumin fractions with different 
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electrophoretic mobility resulting in a bicuspid pattern on serum electrophoresis. 
Bisalbuminemia has been diagnosed by electrophoresis in two bottlenose dolphin (Tursiops 
truncatus) families, but causative mutations and the inheritance pattern have not been 
identified. The aims of this work are: to investigate polymorphisms of the bottlenose dolphin 
albumin gene and to identify mutations causative of bisalbuminemia; to identify the inheritance 
pattern in two bottlenose dolphin families. Coding regions of the albumin gene were screened 
for mutations in 15 bottlenose dolphins kept under human care from two distinct families. 
Eighteen albumin mutations (three synonymous and 15 non-synonymous) were identified. Two 
non-synonymous variations co-segregated with bisalbuminemic phenotype: p.Phe146Leu in 
exon 4 and p.Tyr163His in exon 5. The amino acid change in exon 5 was associatedwith the 
secondary and/ or tertiary structure variation of the protein and has been reported as causative 
of bisalbuminemia in humans. Pedigree analysis of the dolphin families showed an autosomal 
codominant inheritance pattern. In this work, the mutations potentially responsible for 
bisalbuminemia were identified and confirmed the autosomal codominant trait in bottlenose 
dolphins. 
3. Bonsembiante F.*, Centelleghe C.*, Rossi G., Giglio S, Madeo E., Gelain M.E., Mazzariol S. 
Clinico-pathological findings in a striped dolphin (Stenella coeruleoalba) affected by 
rhabdomyolysis and myoglobinuric nephrosis. J Vet Med Sci. 2017. (*Bonsembiante F. and 
Centelleche C. equally contributed to this article),  
Abstract. A striped dolphin (Stenella coeruleoalba) calf stranded alive because of a Salter-
Harris fracture type 1 of a caudal vertebra and remained in a provisional rehabilitation facility 
for 3 days where the fracture stabilization was attempted, but he died the day after bandaging. 
Serum and urine samples were collected during hospitalization (days 1, 2 and 3 serum and day 
2 urine). Serum analysis 29 showed increased urea, alanine transaminase, aspartate 
transaminase, and serum amyloid A values, while creatinine was below the lower limit. Urine 
analysis showed urinary protein-to-creatinine ratio of 5.3 with glomerular proteinuria. 
Postmortem analyses demonstrated a severe rhabdomyolysis and myoglobinuric nephrosis, 
suggestive of capture myopathy syndrome. We report, for the first time, the clinico-pathological 
changes during this condition in a striped dolphin. 
92 
 
List of original publications regarding other research 
projects 
4. Benali S.L., Lees G.E., Nabity M.B:, Mantovani R., Bonsembiante F., Aresu L. De novo 
expression of human leukocyte antigen-DR (HLA-DR) and loss of beta-catenin expression in 
tubular epithelial cells: a possible event in epithelial-mesenchymal transition in canine renal 
diseases. Vet J. 2013; 198:229-234. 
Abstract. Tubulointerstitial fibrosis (TIF) plays a central role in the progression to end-stage 
renal disease. Tubular epithelial cells (TECs) undergo epithelial-mesenchymal transition 
(EMT) and may contribute to the progression of TIF. Using immunohistochemistry, the primary 
aim of this study was to assess the expression of β-catenin, human leukocyte antigen-DR (HLA-
DR) and vimentin in renal biopsies from dogs with spontaneous kidney diseases of varying 
severities. Morphological diagnosis, severity of inflammation, TIF, HLA-DR expression and 
clinico-pathological variables were compared in dogs with renal injury to identify any potential 
relationship between the different factors; β-catenin down-regulation was used as a marker of 
EMT. Fibrosis, HLA-DR expression, serum creatinine concentration (SCr), and urine protein-to 
creatinine ratio (UPC) were all increased and β-catenin expression decreased in dogs with 
primary glomerular disease compared with dogs with acute tubular necrosis. HLA-DR 
expression by TECs was positively correlated to fibrosis, inflammation, UPC, and SCr. β-
catenin expression was negatively correlated to fibrosis, inflammation, and HLA-DR 
expression. The progression of renal failure correlated closely with tubulointerstitial damage. 
De novo HLA-DR expression associated with β-catenin down-regulation by TECs may 
represent a possible step in the progression of TIF and EMT. 
5. Bonsembiante F., Benali S.L., Trez D., Aresu L., Gelain M.E. Histological and 
immunohistochemical characterization of feline renal cell carcinoma: a case series. J Vet Med 
Sci. 2016; 178:1039-1043. 
Abstract. Four feline renal cell carcinomas (RCCs) were examined using histopathological ind 
immunohistochemical procedures. Specimens were classified by predominant histological 
pattern according to WHO criteria. A panel of antibodies including β-catenin, C-KIT, VEGF, 
VGF-R2 and double immunostaining for vimentin/cytokeratin and for E-cadherin/CD10 was 
selected to characterize the tumors. Neoplasms were classified as tubular (3/4) and papillary 
(1/4). Neoplastic epithelial cells were cytokeratin, vimentin, E-cadherin, VEGF-R2 positive and 
C-KIT negative; 3 cases were β-catenin positive, whereas only two tumors were CD10 and 
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VEGF positive. No correlation with histotype was evident. Our results confirm the low 
frequency of RCCs in cats and suggest a histological pattern similar to canineRCCs. In 
contrast, a peculiar immunohistochemical profile different from both canine and human RCCs 
is identified. 
6. Zorzan E., Da Ros S., Musetti C., Shahidian L.Z., Coelho N.F., Bonsembiante F., Létard S., 
Gelain M.E., Palumbo M., Dubreuil P., Giantin M., Sissi C., Dacasto M. Screening of candidate 
G-quadruplex ligands for the human c-KIT promotorial region and their effects in multiple in-
vitro models. Oncotarget. 2016; 7:21658-21675. 
Abstract. Stabilization of G-quadruplex (G4) structures in promoters is a novel promising 
strategy to regulate gene expression at transcriptional and translational levels. C-KIT proto-
oncogene encodes for a tyrosine kinase receptor. It is involved in several physiological 
processes, but it is also dysregulated in many diseases, including cancer. Two G-rich sequences 
able to fold into G4, have been identified in C-kit proximal promoter, thus representing suitable 
targets for anticancer intervention. Herein, we screened an ‘’in house’’ library of compounds 
for the recognition of these G4 elements and we identified three promising ligands. Their G4-
binding properties were analyzed and related to their antiproliferative, transcriptional and 
post-transcriptional effects in MCF7 and HGC27 cell lines. Besides C-KIT, the transcriptional 
analysis covered a panel of oncogenes known to possess G4 in their promoters. From these 
studies, an anthraquinone derivative (AQ1) was found to efficiently downregulate C-KIT mRNA 
and protein in both cell lines. The targeted activity of AQ1 was confirmed using C-KIT-
dependent cell lines that present either C-KIT mutations or promoter engineered (i.e., a155, 
HCN1.2 and ROSA cells). Present results indicate AQ1 as promising compound for the target 
therapy of C-KIT-dependent tumors, worth of further and in depth molecular investigations. 
7. Perazzi A., Bonsembiante F., Gelain M.E., Patruno M., Di Iorio F., Migliorati A., Iacopetti I. 
Cytology of the healthy canine and feline ocular surface: comparison between cytobrush and 
impression technique. Vet Clin Path. 2017; 46: 164-171. 
Abstract. Impression cytology (IC) is a noninvasive technique in which filters are used to 
sample superficial layers of ocular epithelium. The aim of this study was to compare cytology 
specimens obtained by IC and cytobrush from healthy canine and feline eyes. Dogs and cats 
were prospectively sampled using polytetrafluorethylene filters on the right eye, and cytobrus 
on the left eye. Wright-Giemsa-stained specimens were evaluated by 2 observers. Cellularity, 
preservation, and morphology of cells and presence of goblet and inflammatory cells were 
scored with a 4-grade scale. Inter-observer agreement and effects of topical anesthesia were 
analyzed. In 20 canine IC samples, 10 showed good cellularity (score 2-3) and 13 good 
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preservation. Superficial epithelial cells (SEC) were present in 13/20 of IC, while basal-
intermediate cells (BIC) were seen in 14/20. In 6/20 and 7/20, goblet and inflammatory cells 
were noted, respectively. In 20 cats, 15 of IC showed good cellularity and 14 good preservation, 
and SEC were present in 16/20 of IC and BIC in 17/20. In 13/20 and 3/20 cats, goblet cells and 
inflammatory cells were noted, respectively. Canine cytobrush specimens appeared well 
preserved (9/20) and had good cellularity (8/20). In feline cytobrush specimens good 
preservation and cellularity were observed in 16/20 and 14/20, respectively. In both species, all 
cell types were present without a clear separation. There was moderate to fair agreement about 
cellular morphology in IC between observers. Specimens obtained with and without anesthesia 
were comparable. Impression cytology allowed collection of samples with maintained 
cytoarchitecture, while cytoplasmatic and nuclear details were often difficult to evaluate. 
8. Banzato T., Bonsembiante F., Aresu L., Zotti A. Relationship of diagnostic accuracy of renal 
cortical echogenicity with renal histopathology in dogs and cats, a quantitative study. BMC Vet 
Res. 2017; 13:24. 
Abstract. Renal cortical echogenicity is routinely evaluated during ultrasonographic 
investigation of the kidneys. Both in dog and cat previous ex-vivo studies have revealed a poor 
correlation between renal echogenicity and corresponding lesions. The aim of this study was to 
establish the in-vivo relationship between renal cortical echogenicity and renal histopathology. 
Thirty-eight dogs and fifteen cats euthanized for critical medical conditions were included in the 
study. Ultrasonographic images of both kidneys were acquired ante mortem at standardized 
ultrasonographic settings. The echogenicity was quantified by means of Mean Gray Value 
(MGV)ofthe renal cortexmeasuredwith ImageJ. A complete histopathological examination of 
both kidneys was performed. Five kidneys were excluded because histopathology revealed 
neoplastic lesions. Only samples affected by tubular atrophy showed statistically different 
values in dog, and histopathology explained 13% of the total variance. MGV was not correlated 
neither to the degeneration nor to the inflammation scores. However, significant differences 
were identified between mildly and severely degenerated samples. Overall, the classification 
efficiency of MGV to detect renal lesions was poor with a sensitivity of 39% and a specificity of 
86%. In cats, samples affected by both tubular vacuolar degeneration and interstitial nephritis 
were statistically different and histopathology explained 44% of the total variance. A linear 
correlation was evident between degeneration and MGV, whereas no correlation with 
inflammation was found. Statistically significant differences were evident only between normal 
and severely degenerated samples with a sensitivity of 54.17% and a specificity of 83.3% and 
MGV resulted scarce to discriminate renal lesions in this species. Renal cortical echogenicity 
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shows low relevance in detecting chronic renal disease in dog whereas it results worth to 
identify severe renal damage in cat. 
9. Schrank M., Bonsembiante F., Fiore E., Bellini L., Zamboni C., Zappulli V., Stelletta C., 
Mollo A. Approccio diagnostico alla mastopatia fibrocistica in una capra: rilievi temrografici, 
ecografici ed isto-patologici. Large Animal Review. 2017; 23:33-37. 
Abstract. The mammary gland diseases are frequent problems in goats and sheep breeding. 
Mastitis, abscesses due to traumatic events, neoplasia, and cystic lesions are the main problems 
that could affect udder and nipple. This clinical case is about a pet spayed female goat with an 
increased volume of the right quarter and nipple (25 cm length, 6 cm width), mammary 
lymphadenopathy (diameter of 5 cm), no mammary gland secretion, pain during milking 
procedures, and no opened duct. Inflammatory processes such as mastitis and abscesses were 
rule out based on the thermographic and ultrasonographic investigations, complete blood cells 
count, serum biochemistry, and fine needle aspiration of the fluid for bacteriological culture. 
The histological diagnosis of fibrocystic mastopathy were performed after the mastectomy. In 
human medicine, these lesions are associated to the breast cystic lesions syndrome, that must be 
differentiated from a neoplastic lesion. It is reported that in goats and sheep that these lesions 
have a multifactorial etiology: hormonal imbalance between oestrogens and progesterone, 
genetic causes, and bacteria. In the present case, no bacteria are present, and the absence of 
the reproductive apparatus rules out the hormonal imbalance. Further studies are needed to 
better characterize these lesions frequently reported in goats. 
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Oral presentations-International congress 
1. Benali S.L., Lees G.E., Nabity M.B., Bonsembiante F., Aresu L. De-novo HLA-DR 
expression in canine renal tubular epithelium: a possible event in epithelial-mesenchymal 
transition. 31st congress of European Society of Veterinary Pathology. London (UK), 04-
07/09/2013. 
2. Bonsembiante F., Perazzi A., Gelain M.E., Patruno M., Migliorati A., Iacopetti I. Cytology of 
the healthy canine and feline ocular surface: comparison between cytobrush and impression 
technique. 17th congress of European Society of Veterinary Clinical Pathology. Lisbon (PO), 
09-12/09/2015. 
3. Beffagna G., Sammarco A., Bonsembiante F., Cavicchioli L., Ferro S., Gelain M.E., Zappulli 
V. The Wnt/beta catenin pathway in canine mammary carcinoma as a potential target of anti-
cancer drugs: an in vivo study. 27th congress of European Society of Veterinary Pathology. 
Bologna (IT), 7-10/09/2016. 
4. Bonsembiante F., Martini V., Bonfanti U., Casarin G., Gelain M.E. Comparison between 
whole slide imaging and optical microscopy in the cytomorphological evaluation of canine 
lymphoma samples. 18th congress of European Society of Veterinary Clinical Pathology. 
Nantes (FR), 18-23/10/2016. 
5. Gili C., Bonsembiante F., Beffagna G., Mazzariol S., Gelain M.E. Hereditary bisalbuminemia 
in Bottlenose dolphins (Tursiops truncatus, Montagu 1821). 45th annual symposium European 
Association for Aquatic Mammals. Genova (IT), 8-11/03/2017. 
6. Bonsembiante F., Beffagna G., Gili C., Rossi G., Giordano A., Paltrinieri S., Gelain M.E. 
Paraoxonase-1 (PON1) in Bottlenose dolphins (Tursiops truncatus): serum activity and genetic 
polymorphisms. 18th International symposium of the World Association of Veterinary 
Laboratory Diagnosticians. Sorrento (IT), 7-10/06/2017. 
Oral presentations-National congress 
1. Bonsembiante F., Benali S.L., Trez D., Aresu L., Gelain M.E. Histological and 
immunohistochemical characterization of feline renal cell carcinoma: a case series. 11th 
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Congresso Nazionale dell’Associazione Italiana dei Patologi Veterinari (AIPVet), Pisa (IT), 
16-18/06/2014. 
2. Gili C., Bonsembiante F., Beffagna G., Mazzariol S., Gelain M.E. Mutations and 
polymorphism in albumin gene of bottlenose dolphin (Tursiops truncatus): the first 
identification of mutations responsible of inherited bisalbuminemia. 13th Congresso Nazionale 
dell’Associazione Italiana dei Patologi Veterinari (AIPVet), Palermo (IT), 13-16/06/2016. 
3. Bonsembiante F., Deganello A., Perazzi A., Gelain M.E., Iacopetti I. Impression cytology of 
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